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PREFACE
Echocardiography plays a vital role in the haemodynamic assessment and structural
complications of infective endocarditis. This tool is central to the diagnosis and
management of patients with endocarditis, as echocardiographic evidence of an
oscillating intracardiac mass or vegetation, an annular abscess, prosthetic valve
partial dehiscence, and new valvular regurgitation, are major criteria in the diagnosis
of infective endocarditis 5 .
By emphasizing the appropriate use of echocardiography, as an essential adjunct to
clinical criteria, the practitioner will be guided in early diagnosis of the disease,
thereby having substantial prognostic implications on a patient. When this study was
planned, it was thought that HIV status influences the patient's predisposition to
developing endocarditis. With this study, it was hoped that the prevalence of
complications and incidence of infective endocarditis in inununocompromised
patients would be determined.
The study protocol was submitted to the Nelson R Mandela Research Ethics
Committee, and that committee has granted approval. The study has been structured




Purpose: The aim was to determine the echocardiographic features of patients with
infective endocarditis, and to compare the findings in HIV positive versus HIV
negative patients.
Methods: This was a prospective study, conducted over three years using the
modified Duke criteria in diagnoses. A control group of age-matched patients with
clinical and echocardiographic evidence of valvular regurgitation, who did not
satisfy the criteria and who underwent surgery was used in comparison.
Results: During this period 91 patients were screened for infective endocarditis. 77
satisfied the criteria for a definite diagnosis of IE. Blood cultures were positive in
46% cases. The commonest organism was S. aureus. Most patients had advanced
valve disruption with heart failure and a high peri-operative mortality. The clinical
features in the two groups of patients was similar. The incidence of
echocardiographic complications was 50.6% in the whole group. Except for leaflet
aneurysms in four HIV positive cases, complications were not more frequent in this
group.
Conclusion: There was a high rate of culture negative cases in this study, probably
related to prior antibiotic usage; in this setting the modified Duke criteria have
diagnostic limitations. There was no difference in the clinical presentation of
infective endocarditis between HIV positive and HIV negative patients. Leaflet






Infective endocarditis (IE) is an infection of the endocardial surface of the heart, and
is caused by the adherence of organisms to damaged endocardium. 1. 2 It usually refers
to microbial, bacterial or fungal infection that occurs as a result of colonization of the
endothelium by microorganisms. 3 Major predisposing factors to endocarditis are
underlying cardiac structural valvular abnormalities, such as rheumatic heart disease,
including the presence of prosthetic heart valves, and central venous access which
provide a nidus for the infecting organism. 4 IE is characterised by many clinical
features, none of which are specific for the condition, and therefore the diagnosis is
determined by the presence of multiple findings, rather than a single test result. 5
Important developments during the last twenty years have facilitated rapid and
accurate diagnosis, and have shown that early aggressive treatment is associated with
improved survival. ° Developments in antibacterial therapy, clinical microbiology,
cardiac imaging and cardiac surgery have revolutionized the diagnosis and prognosis
of IE. 1 With the introduction of antibiotics, the mortality rate has decreased to 24%, so
much so that heart failure from valve damage, rather than uncontrolled infection, has
now become the leading cause of death. 7 IE remains a challenging condition however,
especially when non-specific clinical features predominate at the time of
presentation. 6
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Major trends that have created new challenges include the emergence of prosthetic
valve endocarditis, intravascular device-related endocarditis, an increase in antibiotic
resistance among aetiologic organisms, increased patient ratio with comorbid
conditions such as diabetes, dialysis-dependant renal failure, and drug abuse. 8 From a
microbiological standpoint, the rise in staphylococcal infections, and the immune
status associated with acquired immune deficiency syndrome (AIDS) pose diagnostic
challenges that also have important implications for management. 8
1.2 Predisposing factors:
1.2.1 Underlying cardiac conditions:
The correlation between pre-existing cardiac disease, the presence of bacteremia, and
the likelihood of an onset of IE, was first described as early as 1923. 9 IE is higher in
patients with existing valvular heart disease, prosthetic cardiac valves or congenital
heart disease, and is more common in the male than the female population. 3 There are
sparse data available for the developing countries. Even with the introduction of
prophylaxis, the incidence of IE is currently estimated between 1.9 and 6.2 infections
per 100 000 persons of the general population in the Western countries. 6 ' 9
Three main haemodynamic factors predispose a patient to infection, and these are a
high-velocity jet stream; flow from a high to a low-pressure chamber; and a narrow
orifice that separates two chambers, creating a pressure gradient. 3 These factors are
found in patients with valvular heart disease and shunts such as ventricular septal
defects (VSD) and patent ductus arteriosus (PDA), which predispose a patient to
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developing IE. 3 Mylonakis and Calderwood have risk-stratified cardiac abnormalities
that are substrates for IE. 2 Associated high-risk predisposing conditions are previous
IE, aortic valve disease, rheumatic heart disease, prosthetic valves, coarctation of the
aorta, and complex cyanotic congenital heart disease.'` Moderate-risk conditions are
mitral valve prolapse with valvular regurgitation, leaflet thickening, isolated mitral
stenosis, tricuspid valve disease, pulmonary stenosis, and hypertrophic obstructive
cardiomyopathy. 2 Low or no-risk conditions are secundum atrial septal defects (ASD),
ischaemic heart disease, previous coronary artery bypass, and mitral valve prolapse
with thin leaflets and absent regurgitation. 2
1.2.2 Factors predisposing to infection:
Certain patients, who are at high risk of infection, tend to be at an increased risk of
developing IE. These include burn patients, patients undergoing bone marrow
transplant, or any other organ transplant patients with arterio-venous (AV) shunts
undergoing chronic haemodialysis, as well as those with permanent pacemakers. 1°
Poor dental hygiene and diabetes mellitus are also conditions associated with an
increased incidence of IE. 2 Intensive care unit (ICU) care predisposes patients to IE
by means of surgery, pressure monitoring catheters, and other intravascular devices. 10
There is a high risk of IE with mechanical heart valves during the first three months of
surgery, compared to the bioprosthetic valves. 2
IE is also known to occur in patients with normal valvular structures. In this instance
IE usually follows a fulminant infection, such as staphylococcal infections. This is
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particularly true in right-sided IE. In the setting of normal cardiac valves, IE is also
known to occur in patients with chronic alcoholism. 9 This is presumably due to loss of
the bacterial filtration of the normal liver. 9 Similarly, the profound immunosuppresion
found in AIDS predisposes these patients to multiple opportunistic infections and
malignancies, including IE."
According to Levy, et al, the risk of Human Immunodeficiency Virus (HIV) positive
patients developing IE is related to their degree of immunodeficiency. 12 The decreased
cluster of differentiation counts (CD4) common to HIV patients is likely to increase
their risk of developing endocarditis. I2 Very little else is known about the nature of the
infecting organisms and the pattern of disease in the immune-suppressed HIV positive
patients. Neither is much known about the nature of complicating IE in patients with
underlying valvular heart disease who are also HIV positive.
1.3 Diagnosis:
A precise diagnosis of IE is mandatory to guide therapy." Rapid diagnosis, effective
treatment and prompt recognition of complications are essential for a good outcome of
IE, which carries a high morbidity and mortality rate: 4
In the presence of bacteremia, valve involvement, peripheral emboli and vascular
phenomena, the diagnosis of IE is straightforward: 5 When coexisting diseases mask
the features of this disease process, a delay in diagnosis or misdiagnosis is common. 5
4
The diagnosis of this disease requires the integration of clinical, laboratory and
echocardiographic data. 2
However, due to the variability in the clinical presentation of this disease, diagnostic
criteria need to both sensitive and specific across all forms of the disease. 15 Previously
developed strategies were fraught with loopholes, until the advent of the Duke
criteria.' 5 The Duke criteria surpassed other criteria previously used in the diagnosis of
IE, as it emphasised the role of echocardiography, which is the key imaging tool for
both diagnosis and assessment of prognosis.
16
 The lack of a valid method to classify
prognostic severity makes management decisions problematic."
To diagnose IE, the Duke criteria require 2 major, I major and 3 minor, or 5 minor
criteria. This classification stratifies patients into 3 categories: definite cases (proven
at surgery), possible cases (not meeting definite criteria), and rejected (no evidence at
surgery).' 5 Three criteria used for rejecting a diagnosis of IE are: (1) a firm alternate
diagnosis for manifestations of IE, (2) clinical manifestations compatible with IE that
resolve < 4 days of antibiotic therapy, and (3) no pathologic evidence of IE found at
surgery.
17
Durack, et at modified the Duke criteria for the diagnosis of IE and proposed 4
categories: definite (intended to identify patients with a very high probability of
having a true-positive diagnosis), possible (for cases consistent with IE that fall short
of definite by clinical criteria, but are not rejected), probable (includes patients who
5
have received more than 4 days of antibiotic therapy), and rejected (where there
appears to be resolution of the manifestations of endocarditis, with 4 days or less of
antibiotic therapy). 18
According to the modified criteria, even in the face of negative blood cultures, the
presence of 1 major and 2 minor criteria, support a diagnosis of 'definite' IE, provided
there are typical echocardiographic findings.
19 
A recent scientific statement by the
American Heart Association (AlIA) recommended that these criteria be used in the
clinical evaluation of patients with suspected 1E. 16
Echocardiography is an important diagnostic tool to assess the extent and
haemodynamic sequelae of valve damage, cardiac complications and to assist in the
management of IE. 26 The usefulness of this modality extends to the detection of
complications, evaluation of cardiac size and function, the establishment of a
reference point for future observations, and the re-evaluation of patients after
intervention. 21 The echocardiographic assessment of structural complications include
valvular disruption (commonly seen with vegetations and flail leaflets), aneurysm
formation (occurs as a result of regurgitant jets creating secondary sites of infection),
perivalvular abscess formation (common in acute endocarditis), fistulae (created by
aneurysms and abscess rupture), coronary artery obstruction (due to vegetation
fragments embolizing), purulent pericardial effusion, and dehiscence of a prosthetic
valve. 15 It also permits assessment of haemodynamic complications which include
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valvular regurgitation, premature mitral valve closure, restrictive mitral inflow
pattern, valvular stenosis, shunts, congestive heart failure, and systemic embolization.
1.4 Limitations to Diagnosis:
Misdiagnosis or a delayed diagnosis is common and is usually the result of variable
clinical presentation. 10 When valvular destruction is severe, patients present with signs
and symptoms of pulmonary congestion from heart failure, and the diagnosis is then
easily localized to the heart valves. In cases of right-sided endocarditis, pulmonary
embolic phenomena and clinical signs of pneumonia predominate, and with left- sided
endocarditis, embolised vegetations may present with central nervous system
symptoms (e.g.stroke), pleuritic or abdominal pain, thereby directing attention away
from the heart. 9
Furthermore, although fever is a common presenting symptom of IE, it may be absent.
Fever varies from very high temperatures associated with rigors, to a prolonged febrile
state associated with weakness and loss of weight. 9 Fever may be absent in congestive
heart failure, severe debility, chronic renal or liver failure, previous use of
antimicrobial drugs, or IE caused by less virulent organsisms. 2 IE in the elderly and in
the immunocompromised patient has an atypical presentation since fever is often
absent in this group of patients.
22
Since a defining feature of endocarditis is bacteremia, blood cultures are considered
one of the most important tools in making the diagnosis of endocarditis. 23 Positive
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blood cultures are considered major diagnostic criteria, and allows for the
identification of the aetiologic agent. 24 While true negative cultures rule out the
diagnosis of endocarditis, blood cultures alone fail to isolate an aetiologic agent in
2.5% to 31% of cases.23 ' 25 New diagnostic approaches which include cultures and
microbiological assessment of vegetations yield a better understanding of blood
culture negative endocarditis. 2 In other published series, negative blood cultures
however, are found in at least 20% of endocarditis patients. 24 Using standard
microbiological culture techniques, culture-negative endocarditis is associated with
antibiotic use, or the presence of an intracellular pathogen, which is not usually
detectable. 23 The Bartonella, Coxiella burnetti, and Brucella species are usually the
most commonly identified species associated with culture-negative endocarditis,
caused by fastidious organisms. 24 In the presence of toxicity with high fever, a new
regurgitant murmur, congestive heart failure (CHF) and evidence of peripheral
embolisation, empirical therapy is usually initiated while awaiting the results of blood
culture. 1°
In addition to the over-diagnosis that accompanies the above approach, certain
illnesses may mimic IE leading to misdiagnosis. These include neoplasias (atrial
myxoma, marantic endocarditis, neoplastic disease and carcinoids), autoimmune
disease (rheumatic carditis, systemic lupus erythematosus [SLE]), polyarteritis nodosa,
and Behcets's), following valvular surgery (intracardiac thrombi, surgical sutures, and
fibrin strands), and lastly, miscellaneous causes (eosinophilic heart disease, ruptured
mitral chordae, and myxomatous degeneration).
24
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While the presence of risk factors are important in raising the suspicion of IE, they do
not contribute to the criteria used by the clinician in making the clinical diagnosis. 26
There have been known cases where fever, symptoms of IE, and positive blood
cultures for certain organisms are obtained, and the diagnosis of IE is not made, even
though the risk factors are present. 26 Furthermore, in the setting of HIV infection, IE
maybe caused by unusual organisms, such as barbonella, salmonella, and listeria. 1
Bacteremia is said to be common in the HIV positive patients, due to the numerous
immunologic defects present in this disease. 27 This raises the question whether IE
may present differently in HIV positive patients.
1.5 Problem overview:
Until recently, cardiac involvement in HIV infection has received little attention. 12
Studies have confirmed that cardiac abnormalities are more common in HIV-infected
people.28 Many cases of heart muscle disease related to HIV infection seems to be
related to an idiopathic lymphocytic myocarditis. 29 Other potential pathogenic factors
include nutritional deficiencies, opportunistic infections, and cardiotoxic effects of
antiretroviral drugs. 29
The prevalence of IE in the HIV-infected population is assumed to be similar to
patients found in other risk groups, and is estimated at 6.3% to 34%." IE is reported to
be common in advanced HIV patients, and mortality increases with a decreasing CD4
count.
10 
According to a study by Himelman
3 1
, et al, cardiac lesions were found to be
uncommon in ambulatory HIV positive patients, despite prior opportunistic infection,
9
with the exception of mitral valve prolapse. The study by Himelman 31 further suggests
that echocardiographically detectable lesions, especially cardiomyopathy was found to
be more common in the patients classified as having AIDS. Many of the
cardiovascular findings of AIDS however are still being elucidated." Since not much
is known about the pattern of cardiac involvement of IE in patients with HIV we
performed an echocardiographic evaluation to further elucidate this problem.
It is known that the degree of immunosuppression, manifested by a reduced CD4
lymphocyte count, strongly correlates with the presence of echocardiographic
abnormalities: 2 An increased risk of IE has not been encountered in children with
congenital or acquired immuno-deficiencies. 32 The immunosuppression associated
with HIV may alter the clinical picture of valvular heart disease, particularly IE.
Therefore, a clearer understanding of the pathogenesis of IE, treatment, and supportive
care becomes essential. The documented increase in the prevalence of HIV-associated
cardiac disease, supported by echocardiographic studies, calls for a careful
cardiological evaluation to determine the pattern of involvement of the heart in the
HIV-positive subjects, who develop 1E, even in patients in the early phases of the HIV
disease. 33
Regarding IE in HIV positive patients, several issues require further clarification:
1. The echocardiographic characteristics of valve involvement
2. Whether HIV positive patients have a different clinical presentation.
3. The value of conventional diagnostic criteria.
10




The aim of this study was to compare clinical and echocardiographic features of IE in
patients with and without concomitant HIV infection.
2.2 HYPOTHESIS:
It is hypothesized, that infective endocarditis in HIV positive patients is associated
with a higher rate of cardiac complications, when compared with HIV negative patients.
2.3 OBJECTIVES:
1. To describe the echocardiographic features of infective endocarditis in HIV positive
patients.
2. To compare the type and prevalence of complications of infective endocarditis in
HIV positive versus that in HIV negative patients.





The study was prospective in nature and screened a total of ninety-one patients with
features of suspected IE between 2004 and 2007. Only patients with a definite diagnosis
of IE according to the modified Duke criteria were enrolled for the purpose of the study.
Inkosi Albert Luthuli hospital (IALCEI) is an eight hundred and forty-two bed, tertiary
referral centre, serving a Kwa-Zulu Natal (KZN) population of ten million people, who
are of a mixed decent. Patients were excluded if they refused participation in the study,
and if they refused HIV testing. One patient refused to participate in the study.
Patients with a clinical diagnosis of IE had an initial examination by transthoracic
echocardiography (TTE), to exclude echocardiographic evidence of infection
(vegetations, paravalvular extension, prosthetic valve dehiscence), haemodynamic
compromise (valvular dysfunction, ventricular dimensions and ventricular function),
and to determine the presence of potential risk factors such as congenital, valvular or
degenerative heart disease. Leaflet or cuspal thickening, with areas of calcification
found at TTE was regarded as suggestion of previous rheumatic heart disease. Where
TTE images were suboptimal, such as mechanical prosthetic valves, and if paravalvular
extension was suspected, transesophageal echocardiography (TEE) was performed
within 24 to 48 hours of admission. (Appendix 1a and lb are the information leaflets
and consent forms used for the purpose of the study, as part of the patient recruitment
procedure).
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The diagnosis of 1E was made by clinical criteria including echocardiography, as well
as pathological results (Appendix 2).
3.1.1 Pathological criteria:
Pathological criteria refer to the demonstration of microorganisms in vegetations or
abscesses, or pathological lesions with confirmatory histology. The organisms were
identified by standard culture practices used in the microbiology laboratory at IALCH.
Standard aerobic and anaerobic culture media were used for culturing of all organisms,
as the aerobic plus culture medium was not available at this facility. Specimens were
incubated for five days to ensure detection of possible fungal infections.
3.1.2 Clinical criteria:
The clinical criteria (modified Dukes) consist of major and minor criteria, which may
include 2 major, 1 major and 2 minor or 5 minor criteria. 8 These criteria are as follows:
Major criteria:
I. Positive blood cultures with organisms typical for endocarditis
2. Evidence of endocardial involvement
Minor criteria:
1. Predisposing heart disease
2. Fever > 38 °C
3. Vascular and immunological phenomena
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4. Microbiological evidence not meeting major criteria
5. Elevated erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) levels
6. Splenomegaly, clubbing, splinter heamorrhages, and petechiae
7. Central and pheripheral venous access
8. Organisms from metastatic lesions and heamaturia. 34
After the clinical diagnosis of IE had been made, an echocardiogram was performed on
a Sequoia C256 (Acuson, Germany) cardiac ultrasound machine, using a 5MHz
transthoracic transducer for TTE, and a 7MHz multiplane transesophageal probe for
TEE. The patients were assessed for the presence of vegetations, severity of valvular
involvement and evidence of complications. These included annular extension of
infection, root abscesses, leaflet aneurysms and tears, fistulae, intracardiac shunts, and
pericardial effusions. Adjustment of gain settings and use of the correct transducer
frequency was made where necessary to reduce or avoid misdiagnoses. Harmonic
imaging (HI) is a modality that is based on the principle of receiving double the emitted
ultrasound frequency (second harmonic), and compared with fundamental imaging (FI),
HI has a better signal to noise ratio between the cavity and wall, with a reduction in the
near field clutter, leading to improved endocardial border delineation and higher image
resolution of valve structures. 35 This modality was used during the echocardiographic
examinations of all participants, where better delineation of the endocardial borders was
thought to enhance the resolution of mobile structures.
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3.2 Study participants:
All patients with suspected IE were referred from hospitals in KZN (Appendix 3) to the
Department of Cardiology at IALCH. The patients were assessed by clinicians who
documented the clinical features of IE. These included pallor; weight loss, splinter
hemorrhages (found beneath fingernails and toenails), clubbing of fingers and toes,
non-specific joint pain, petechia (small purpuric spots of blood beneath the skin
surface) found on the legs and chest, Roth spots (small white spots seen in the retina),
Osler's nodes (small, swollen, tender area found on the fingers or toes), and rarely,
Janeway lesions, which are raised nodular haemorrhagic lesions that are relatively
painless. 4 Blood sampling was performed for estimation of ESR, CRP, serum
complement (C3 C4), and blood cultures. Urine was tested for microscopic haematuria.
Twelve-lead electrocardiograms were performed on almost all of the patients, to
exclude the presence of an-hythmias.
All study participants were tested for HIV (the diagnosis of HIV was determined by an
ELISA test), after adequate pre-test counseling by a qualified counselor. If the results
were positive, a CD4 count was done. CD4 counts were obtained for all HIV-positive
patients. The stage of HIV infection was assessed using both clinical features and the
level of CD4 count. A team of physicians, cardiologists, microbiologists, cardio-
thoracic surgeons and councilors were involved in the care of these patients, especially
those requiring cardiac surgery.
A broad description of the echocardiographic features of IE was documented for the
16
study population as a whole. Patients were then classified based on their HIV test result
and the clinical features, laboratory results and echocardiographic findings compared in
the two groups (Appendix 4).
The research study was done on patients who had consented to participate, and who had
consented to HIV testing. If patients declined HIV testing, they were excluded from the
study. These patients were then referred back to their district level hospitals for
appropriate follow-up programs.
3.3 Echocardiographic analysis:
The subsequent paragraphs are a description and elaboration of the echocardiographic
features that were used for the purpose of the study.
(i) Vegetation
A vegetation was defined at echocardiography as a discrete echogenic mass seen
adherent to a point on the valve leaflet, with distinct characteristics from the leaflet. 36
When identified , vegetations were characterized by four physical properties; (1) size;
(2) mobility, further classified as fixed, fixed at base, pedunculated, or prolapsing; (3)
extent, determined by single, multiple, involving multiple leaflets, and extention to
extravalvular structures; (4) consistency, defined as complete calcification, partial
calcification, denser than the myocardium without calcium, and consistency equal to
the myocardium. 36
[Figure 1(a), 1(b), 1(c), 1(d) and 1(e)]
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(ii) Leaflet aneurysm
An aneurysm, particularly of the mitral valve, was defined as a saccular cavity bulging
towards the left atrium in systole, which collapsed during diastole. 9
[Figure 2(a) and 2(b)]
(iii) Abscess
An abscess was considered to be present when echolucent cavities within the valve
annulus or adjacent myocardium were found in the setting of valve infection. 35 The
recommended criteria for echocardiographic evidence of aortic root abscesses are:
• prosthetic valve 'rocking'
• aneurysms in the region of the sinus of valsalva
• thickness of the anterior and posterior wall of the aortic root >10mm
• a perivalvular density in the septum >14mm. 37
[Figure 3 (a) and 3(b)]
(iv) Fistula
Under the influence of systemic intravascular pressures abscesses can progress to
fistulous tracts, creating intracardiac shunts.' 5 A fistula was considered to be present
when colour Doppler showed the presence of abnormal flow communicating a great




The presence of a pericardial effusion, (an echolucent space between the epicardium
and pericardium) the amount and distribution of fluid can be demonstrated on an
echocardiogram. 21 When present, the size, and the echogenicity of the effusion was
determined.
[Figure 4(a) and 4(b)1
(vi) Leaflet or cuspal perforation
A perforation was considered to be present when an interruption of echoes was
recognised along the leaflet, or cuspal surface, as defined by Taams, et al. 38
(vii) Ruptured chord
The presence of a chordal rupture was recognised by the 'whipping' systolic motion of
a leaflet tip, with failure of leaflet coaption. 38
After the procedure an assessment was made as to whether the patient had
echocardiographic indications for surgical intervention. Three echocardiographic
features suggesting the potential need for surgery in patients with IE were examined:
(1) vegetations — persistent vegetations after systemic embolization, particularly
>10mm, showing an increase in size after four weeks.
(2) valvular dysfunction — perforation or leaflet rupture, valvular insufficiency with
signs of ventricular failure, unresponsive to medical therapy.
(3) paravalvular extension - valvular dehiscence; rupture or fistula formation with
19
new heart block, and large abscesses. I5
3.4 STATISTICS 
This is both a descriptive and an analytical study of the echocardiographic findings in
IE. Simple comparisons of the clinical and echocardiographic features were made of the
findings in HIV positive and HIV negative patients. Comparisons between HIV positive
and HIV negative patients for categorical outcomes (e.g. valvular assessment) were
evaluated by means of chi squared tests or Fischer's exact tests. Where the outcome
was numerical (e.g. CD4 count) Mann-Whitney tests were used to compare mean ranks
in the HIV positive and HIV negative groups. The t test was used to determine the
differences between samples. The significance level (p value) was taken at 0.05.
Baseline characteristics of all patients were evaluated to identify any underlying risk
factors, and to determine the mean age and gender distribution (Appendix 5).
3.5 ETHICS 
The study protocol was approved by the Nelson R Mandela Research Ethics Committee
( H095/04), and permission for the study received approval from the hospital board, at
IALCH. The study has been structured in accordance with the Declaration of Helsinski





Of the ninety-one patients screened for suspected endocarditis, a total of seventy-seven
patients were classified with a 'definite' diagnosis of IE, nine as 'possible' endocarditis,
and five as 'rejected' endocarditis, according to the modified Duke criteria. All consented
to HIV testing and inclusion in the study: seventeen were HIV positive, and sixty were
HIV negative. The diagnosis and the descriptive features in these patients is based on
the modified Dukes and for comparison, the Dukes criteria is shown below (table 1).














Definite 16 (88.9) 47 (64.4) 63 17 (94.4) 60 (82.2) 77
Possible 2 (11.1) 21 (28.8) 23 1 (5.6) 8 (10.9) 9
Rejected 0 (0) 5 (6.8) 5 0 (0) 5 (6.8) 5
Amongst the HIV positive patients, seventeen were classified as 'definite' IE, and the
remaining one, as 'possible' IE. This patient had one major criterion (vegetations on the
aortic valve) and one minor criterion, which was an elevated ESR level. Twelve
patients were lost to follow-up (seven HIV negative, and five HIV positive). Of these
ten were classified as 'definite' IE, and two as 'possible' IE. Five of the HIV positive
patients underwent surgery, four were 'definite' IE, and one was 'possible' IE. The
surgical findings were positive for the four 'definite' cases, while in the remaining HIV
2 1
positive patient with 'possible' endocarditis there was no evidence of IE: the valve
cusps were normal with failure of coaption.
Amongst the HIV negative patients, sixty were classified as 'definite' IE, and eight as
`possible' IE. Five patients were rejected, because of only one major criterion with no
minor criterion (two), or because of only one to two minor criteria (three). These major
criteria were vegetations of the mitral valve in one patient, and vegetations of the
tricuspid valve in the other patient. Of the thirty-four HIV negative patients referred for
surgery, twenty-nine were 'definite' endocarditis, four were 'possible' endocarditis, and
one was 'rejected' endocarditis.
From the nine 'possible' endocarditis patients, four had surgery for valve replacements,
one had a PDA ligation, and the remaining four had ultimate diagnoses of rheumatic
heart disease. Of the five 'rejected' endocarditis patients, one had surgery for a valve
replacement, one was diagnosed as an Ebsteins anomaly, and the remaining three
diagnoses were rheumatic heart disease.
One patient with definite staphylococcus aureas (S. aureas) endocarditis, secondary to
an infected central venous line, was excluded from initial screening because he declined
participation in the study.
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4.2 Demographic data
The mean participant age in the whole group was approximately thirty years, and there
were no significant differences in age, admission weight (61kg vs. 59kg), and
temperature (36.5°C vs. 37°C) between the HIV positive and HIV negative patients.
Overall, there was a slight male predominance for the occurrence of IE in both groups
of patients, 54.5% (n=42) were male and 45.5% (n=35) were female. Despite the fact
four patients had AIDS as defined by the Centre for Disease Control (CDC) criteria at
presentation, none of the patients in the HIV positive group had significant weight loss
(table 2).
Table 2: Demographic comparison of HIV positive and HIV negative patients
HIV (+) n=17 (%) HIV (-) n=60 (%) P value
Age 32 (22 — 50)* 31 (12 — 64) * .867
Gender - male 9 (53) 33 (55) 1.000
- female 8 (47) 27 (45)
Weight 61 (41 — 82) * 59 (43 — 79) * .585
* Mean values with the ranges bracketed.
4.3 Clinical parameters
Of all the clinical stigmata of IE, clubbing and heart failure were the most common,
found in forty-three (55.8%) patients, and thirty-three of (42.9%) patients respectively.
In both the HIV positive and HIV negative patients, clubbing was the most common
extracardiac feature. Although the presence of fever was found to be higher in the HIV
positive patients, only four patients had temperatures above 38 °C. Embolic phenomena
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or stroke, occurred in three patients in the HIV positive and six in the HIV negative
group; the differences were not statistically significant.
Regurgitant murmurs were documented in all but one patient, who had repeated blood
cultures positive for propriobacterium. Hepatomegaly mirrored the findings of
congestive heart failure and was found in five (29.4%) HIV positive patients, and in
twenty-eight (46.7%) HIV negative patients (table 3). First degree heart block was seen
in the twelve lead electrocardiograms of fifteen patients, complete heart block was
found in one patient, an intraventricular conduction defect was found in five patients,
and one patient had a ventricular trigeminal rhythm. The remaining electrocardiograms
showed right bundle branch block (n=3), left bundle branch block (n=4), sinus
tachycardia (n=5), sinus bradycardia (n=1), left ventricular hypertrophy (n= 10), left
atrial enlargement (n= 2), right atrial enlargement (n=1), ventricular extra systoles
(n= 5), junctional rhythm (n=1), atrial fibrillation (n=2), and seven patients had normal
findings.








Fever 4 (23.5) 3 (5) 7 (9.1) .024
Clubbing 11 (64.7) 32 (53.3) 43 (55.8) .102
Splinter haemorrhages 2 (11.8) 3 (5) 5 (6.5) .304
Emboli / stroke 3 (17.6) 6 (10) 9 (11.7) 1.000
Splenomegaly 2 (11.8) 3 (5) 5 (6.5)
Heart failure 5 (29.4) 28 (46.7) 33 (42.9) .204
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4.4 Laboratory results:
The ESR and CRP were markedly elevated in all patients, the degree of elevation being
higher in the HIV positive patients. The haemoglobin level was lower in the HIV
positive group but the differences were not statistically significant. Overall, thirty-seven
(48%) of the patients had a positive result for rheumatoid factor. The serum
complement (C3) was significantly lower in the HIV negative group (p = 0.001); this
was probably due to the lower serum albumin in this group. There was no difference in
the white cell counts between the two groups (table 4). Significantly elevated counts
were recorded in fourteen HIV negative and in four HIV positive patients. Markedly
elevated counts were recorded in patients infected with S.aureus (four HIV negative
and one HIV positive), two staphylococcus epidermis (S. epidermis) (both HIV
negative), three pseudomonas aeruginosa (P. aeruginosa) (all HIV negative), four
streptococcus viridans (S. viridans) (all HIV negative), one serratia marcescens
(S. marcescens) (HIV negative), and three with negative blood cultures, who were HIV
positive.
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Table 4: Laboratory results
Lab findings HIV (+) n=17 (%) HIV (-) n=60 (%) P value
White blood count CH 7.7 (2.46 - 23.14) 8.7 (4 - 29.4) .387
Lymphocyte (/1) 2.76 (0.44 - 18.2) 2.93 (0.26 - 6) .548
Platelets (/1) 273 (123 - 449) 229 (40 - 432) .675
Haemoglobin (mg/di) 8.92 (5 -11.2) 10.76 (6 -14.2) .119
Sedimentation rate ( mm/Hr) 110.8 (65 - 142) 62.5 (6 - 160) .024
C-reactive protein (mg/L) 95.19 (0.17 - 265.3) 52.6 (0.02 - 336.4) .018
Urea(mmol/I) 7.6 (3 - 192) 13.87 (1.4 - 28.3) .091
Creatinine (mmo1/1) 131.6 (57 - 770) 201.42 (43 -851) .301
Serum albumin ( g/d1) 26.94 (18 - 36) 31.35 (0.57 - 49) .031
Complement 3 (g/1) 1.48 (1.1 - 1.77) 1.09 (0.15 - 1.8) .001
Complement 4 (g/1) 0.308 (0.13 - 0.46) 0.25 ( 0.01 - 0.52) .120
Rheumatoid factor (+) 4 (23.6%) 33 (55%) .052
Haematuria 3 (17.6%) 19 (31.7%)
All are mean values with the ranges bracketed, except rheumatoid factor and haematuria
4.5 The Infecting Organism
Thirty-five patients (46.7%) had positive blood cultures; twenty-eight of these were
from the HIV negative patients, and seven were from the HIV positive patients.
S. aureus was the most common infecting bacterium for the both groups of patients, and
was found overall in sixteen (45.7%) of those with positive cultures. Of these, twelve
were HIV negative patients, and four were HIV positive. The second most common
infecting bacterium was S. viridans; seven patients (20%) were infected with this
bacterium. Of these one was in the HIV positive patients, and six in the in the HIV
negative patients. Two HIV positive patients were infected with unusual organisms
(propionibacterium and streptococcus faecalis [S. .faecalis]) (table 5). All patients
received appropriate antibiotic treatment at the referring hospitals for infective
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endocarditis. The standard treatment in culture negative cases was penicillin plus
aminoglycoside administered intravenously. The exact doses could not be retrieved.
Table 5: Infective Organism
Bacterium HIV(+) n=17 HIV (-) n=60 Total
Staph aureus 4 12 16
Strept viridans 1 6 7
Staph epidermis 4 4
Moraxella catarrhalis 1 1
Pseudomonas aeruginosa 3 3
Serratia marcescens 1 1
Propionibacterium 1 1
Streptococcus faecalis 1 - 1
Corynebacterium 1 1
Culture-negative 10 32 42
Total 17 60 77
The underlying valve morphology was studied carefully to determine whether there
was any evidence of previous disease. In most instances the infected valve was
thickened, suggesting a rheumatic aetiology. S. aureus was the bacterium found to be
most common in these cases (table 6). In eighteen cases (ten HIV negative and eight
HIV positive) the valve leaflets were thin and mobile, and therefore thought to be
normal. The presence of excess valve echoes with prolapse indicated the prolapsing
leaflet syndrome in six patients (two HIV positive and four HIV negative).
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Table 6: Organisms affecting normal and abnormal valves
HIV(+) HIV(-)
Organism Normal valves Thickened valves Normal
valves
Thickened valves
S. aureus 2 2 2 10
S. viridans 1 - - 6
Staph epidermis - - - 4
M. catarrhalis - - 1 -
P. aeruginosa - 1 1
Serratia marcesccns - - 1
Propionibacterium 1 - -
S. faecalis 1 - - -
Corynebacterium - - 1 -
Culture-negative 3 7 5 25
Total 8 9 10 47
Three HIV negative patients had prosthetic IE; one of them had Pseudomonas aeruginosa IE
4.6 Echocardiographic findings
All but one patient (n=76) had findings suggestive of infective endocarditis on TTE.
These positive findings included the presence of vegetations, root abscesses or leaflet
aneurysms. Overall, sixty patients had echocardiographic features suggestive of
rheumatic heart disease: of these fifty-one were HIV negative, and nine were HIV
positive. These echocardiographic features included thickened valves, failure of leaflet
coaption, and leaflet prolapse, which were regarded as possible predisposing factors to
infection. Congenital defects were found in five patients, three of whom were patients
with VSD (1 HIV positive and 2 HIV negative). Of the remaining 2 patients, 1 had a
bicuspid aortic valve, and the other a PDA, both of whom were HIV negative.
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Fifty-four (70.1%) patients had a TEE (which was used as an additional confirmatory
tool to exclude the presence of cardiac complications), of whom fifty-one had features
to suggest IE. The remaining three patients with negative findings at TEE had thickened
calcified valves (1), thickened leaflets with chordal rupture (I), and the last one had a
normal valve.
4.6.1 Vegetations
Vegetations were the predominant finding in sixty-eight (88.3%) patients at
echocardiography (table 7). Vegetations were found in eleven (64.7%) of the HIV
positive patients, and in fitly-seven (95%) of the HIV negative patients. The remaining
nine patients (six HIV positive and three HIV negative patients) showed no evidence of
any vegetation, but had other features suggestive of IE. These were leaflet aneurysms in
four and aortic root abscesses in five cases; the remaining patient had a disrupted aortic
valve without the presence of vegetations.









Vegetations 11(64.7) 57(95) 68 (88.3) 0.447
Leaflet Aneurysm 4 (23.5) 1 (1.7) 5 (6.5) .008
Abscess 3 (17.6) 3 (5) 6 (7.8) .118
Regurgitation 16 (94.1) 59 (98.3) 75 (97.4)
Pericardial effusion 6 (35.3) 26 (43.3) 28 (36.4) 1.000
Chordal rupture/leaflet prolapse 6 (35.3) 20 (33.3) 26 (33.8)
Overall, vegetations were found mainly on the mitral and aortic valves. Twelve patients
had vegetations on both the mitral and aortic valves; one patient with a VSD had
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vegetations on the mitral and tricuspid valves. In the HIV negative patients, twenty-one
had vegetations on the aortic valves, and twenty-one had vegetations on the mitral
valves, compared to the HIV positive cases in whom two had vegetations of the aortic
valve, and four had vegetations of the mitral valve. (Figure la, lb, lc and Id)
In the six patients with right-sided endocarditis, vegetations were seen on the tricuspid
valve in two HIV positive and two HIV negative patients, in the remaining two HIV
negative patients vegetations were located on the pulmonary valve and at the tip of the
central venous line. (Figure le)
In both groups vegetations were either echogenic or homogenous in appearance, with
an irregular shape. Thirty-eight patients (49.4%) had a single vegetation, and thirty
patients (38.9%) had multiple vegetations (table 8). In the HIV positive patients, the
presence of single and multiple vegetations was seen with the same frequency. The HIV
negative patients however, were more likely to have a single vegetation, although this
was not a significant difference. Vegetation size was found to be slightly increased in
the HIV positive patients (11mm), compared to the vegetations seen in the HIV
negative patients (10mm) but this was not a significant finding (p value = 0.447). In all
cases vegetations were accompanied by significant regurgitation of the affected valve.
There was no difference in the severity of regurgitation between the groups. One
patient, who was HIV positive, had bacteremia (propionibacterium), but had no
evidence of vegetations at echocardiography. In this case the diagnosis of IE was based
on the presence of bacteremia, early clubbing and an elevated ESR and CRP level
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(62mm/Hr and 151 mg/L respectively).
There was no relationship between the size of the vegetation and the presence of
complications such as abscess formation, aneurysm, stroke or fistula development. Four
HIV negative patients with vegetations >10mm had complications, which included an
abscess in one, a fistula in another (Figure 3c), and two of whom had strokes. None of
the HIV positive patients had complications associated with large vegetations. Large
vegetations were seen in four HIV positive patients, and thirteen HIV negative patients.
Table 8: Vegetation characteristics at echocardiography
HIV (+) n=17 HIV (—) n=60 Total P value
Site
Aortic 2 (11.8) 21 (35) 23 (29.9) .189
Mitral 4 (23.6) 21 (35) 25 (32.5) .001
Tricuspid 2 (11.8) 1 (1.7) 3 (3.9)
Other site *** 0 {0) 4 (6.7) 4 (5.2)
Mixed (aortic + mitral) 3 (17.6) 10 (16.7) ** 13 (16.9)
Mean size (mm) 11(4 — 24) * 10 (3 — 30) * 10(3-30) 0.447
Vegetation number
Single 6 (35.3) 32 (51.7) 38 (49.4)
Multiple 5 (29.4) 25 (41.7) 30 (38.9)
Total n (%) 11 (64.7) 57 (95) 68 (88.3)
Values expressed in brackets indicate percentages.
* Mean values with the ranges bracketed
** Includes one patient with a VSD who had mitral and tricuspid valve vegetations
*** "Other site' refers to central line, pulmonary and prosthesis valves. The left atrial mural
endocarditis is included with the mitral valve.
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Left sided 1E:
HIV positive (Figure] a and lb)
Vegetations on the aortic valve (left) and mitral valve (right) in a HIV positive patient
HIV negative (Figure lc and 1d)
Vegetations on the aortic valve (left) and mitral valve (right) in a HIV negative patient
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Right sided IE:
HIV negative (Figure le)
Involvement of the tricuspid valve in the patient with a VSD
4.6.2 Leaflet aneurysms
Leaflet aneurysms were found in four of the seventeen HIV positive patients, (23.5%),
affecting both the mitral and aortic valves with equal frequency. Among the HIV
negative patients, one had a leaflet aneurysm associated with a vegetation <10mm,
affecting the mitral valve. The leaflet aneurysms appeared larger in size in the HIV
positive patients (0.86cm depth x 0.85cm width), compared to the smaller sized
aneurysm in the HIV negative patient (0.21cm depth x 0.3cm width) (p = .008).








HIV negative (Figure 2b)HIV positive (Figure 2a)
Leaflet aneurysm on the aortic and mitral valves in a HIV positive patient and on the
mitral annulus in the HIV negative patient
4.6.3 Aortic root abscesses
Aortic root abscesses were found in three of seventeen HIV positive patients (17.6%),
and in three HIV negative patients, (5%) (table 7). As in the leaflet aneurysms, the
aortic root abscesses were of a larger size on echocardiography in the HIV positive
patients (0.73cm depth x 1.2cm width), compared to the HIV negative patients (0.3cm
depth x 0.45cm width) (p = .118). There was no evidence of myocardial abscess
formation. Pericardial effusion associated with a root abscess was found in two HIV
negative patients, measuring 1.5cm and 1 cm respectively, one of whom had heart
failure. Five patients with aortic root abscesses had features of first degree heart block







HIV positive (Figure 3a) HIV negative (Figure 3b)
Aortic root abscess involving the non coronary cusp of the aortic valve
HIV negative (Figure 3c)
Fistulous connection between a root abscess and the right atrium
4.6.4 Pericardial effusion
Pericardial effusion was more common in the HIV negative patients, a surprising
finding, since it has been reported by Katz39, et al, that there is generally a strong
correlation between pericardial effusions and compromised immune status. It was
detected in twenty-six (43.3%) HIV negative patients, compared to six (35.3%) HIV
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positive patients (p = ns) (table 7). The effusions were attributed in all but one case to
accompanying heart failure, although myocardial abscess formation could not be
entirely excluded on echocardiography as the possible aetiology. The average size of
the effusion was the same in both groups (1.4cm). Large effusions (>1.5cm) were seen
in one HIV positive and nine HIV negative patients. The remaining patients had
effusion measuring 1.5cm and less. Most pericardial effusions were simple, without
fibrin strands or loculation, except in one HIV negative patient whose 1.2cm effusion
demonstrated the presence of fibrin strands. This patient had been treated previously for
disseminated tuberculosis (TB). The patient subsequently demised. An autopsy
however, was not performed. There was a single case of a pericardial effusion
associated with the presence of an aortic root abscess in a HIV negative patient. This
patient had a sinus of Valsalva fistula, but there was no evidence of rupture into the
pericardial space at echocardiography, or at surgery. At operation the non-coronary
cusp was completely eroded, with an aortic root abscess beneath it, with fistulation into
the right atrium. The patient demised during surgery, as a result of coronary ostial
occlusion.
Twenty-two of the twenty-six HIV negative patients with pericardial effusions had
severe valvular regurgitation and twelve (46.2%) showed signs of advanced heart
failure with fluid overload. All six HIV positive patients with pericardial effusions had
severe valvular regurgitation, and two had signs of advanced heart failure. Pericardial
effusions were detected in two of the four patients with AIDS, measuring an average
size of 1.8cm. These effusions attributed to heart failure in one patient and to
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tuberculosis in the other.
HIV negative (Figure 4a) HIV positive (Figure 4b)
Pericardial effusion in two patients with mitral valve involvement
4.6.5 Left ventricular function:
The ventricular dimensions in the HIV negative patients were slightly increased
compared to the HIV positive patients (table 9). Although three patients had ejection
fractions <40% (all HIV negative), eleven had an ejection fraction 40 — 50% (one HIV
positive and ten HIV negative), and the remaining patients had ejection fraction >50%
(sixteen HIV positive and forty-seven HIV negative). Overall, neither group of patients
demonstrated reduced ventricular contractility on the echocardiogram. The mean
ejection fraction (EF) in the HIV negative patients was 59%, and in the HIV positive
patients, 62.9%. The three HIV negative patients who had ejection fractions <40%, had
aortic valve regurgitation. None of the HIV positive patients had reduced systolic
function.
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Table 9: Haemodynamic Parameters and Ventricular systolic function
Mean dimensions HIV(+) HIV(-)
End diastolic dimension 62.7mm (41 — 76) 66.5mm (37 — 103)
End systolic dimension 39.6mm (22 — 56) 42.3mm (6 — 74)
Fractional shortening 36.6% (22 -48) 34.6% (21 —48)
Ejection fraction 62.9% (43 — 75) 59% (35 — 79)
Pulmonary artery pressure 61 (29 - 91) 57 (20 — 110)
Heart failure 5 (29.4%) 28 (46.7)
All are mean values with the ranges bracketed.
Regional wall motion abnormalities (RWMA) were found in seven (11.6%) HIV
negative patients, and one HIV positive patient. In the HIV negative patients, the
RWMA were due to paradoxical septal wall motion (SPSM) from severe tricuspid
regurgitation, except one who had posterior wall hypokinesis. There was no evidence to
suggest myocardial infarction. The EF in this group with SPSM was 48% in the HIV
negative patients. Of the patients with RWMA, the electrocardiogram findings were
complete heart block in one patient, first degree heart block in two patients, left bundle
branch block in two patients, intraventricular conduction defect in one patient, and
normal findings in two patients. In the HIV positive patient, the EF was 43%.
4.6.6 Underlying valve pathology
At TTE the underlying valve tissue was found to be abnormal (thickened, stenotic
valves, failure of leaflet coaption with restricted leaflet motion, and leaflet prolapse) in
fifty-seven patients, of whom forty-eight were HIV negative, and nine were HIV
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positive. The remaining seventeen patients had normal valves (nine HIV negative and
eight HIV positive) Aortic and mitral valve stenosis was seen in both groups of
patients, which was most likely due to underlying rheumatic valve disease.
TEE was performed as soon as possible after admission, to confirm the findings on
transthoracic imaging, except where it was technically not feasible or the patients
judged to be too ill for the procedure. It was also performed if there were changes in the
clinical picture, lack of improvement on medical therapy, or if complications were
suspected. Fifty-four of the study patients had TEE, of whom fifty-one had findings
suggestive of IE. The remaining three patients had thickened calcified valves (n=1),
thickened leaflets with chordal rupture (n=1), and normal valves (n=1). Seven of nine
patients suspected on transthoracic imaging to have complications such as root
abscesses and leaflet aneurysms, had positive findings at TEE; the remaining two did
not have the procedure, as they were unable to tolerate the probe.
4.6.7 Complications
Extensive valve disruption was present in both groups, since patients presented at an
advanced stage of infection. Except for leaflet aneurysms and root abscesses, which
were present in four and three HIV positive patients respectively, there did not appear
to be any difference in the prevalence of valve-related complications between the two
groups (table 10). Valve disruption due to chordal rupture, and perforated or flail
leaflets, were equally distributed in the two groups. There were no striking differences
with regards to the shape of vegetations. In both groups ejection fraction as an indicator
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of contractility was good, except for three patients in the HIV negative group whose
values were below 40% (20, 20, and 35). Clinical heart failure with fluid overload was
more frequent in the HIV negative group (table 3).
Table 10: Valve-related Complications
HIV(+) n=17 HIV(-) n=60
Chordal rupture
Chordal rupture with fluttering 2 4
Flail leaflets - 1









Leaflet Perforation 1 1










mild 1 (5.9) 3 (5)
moderate 3 (17.6) 6 (10)
severe 13 (76.4) 49 (81.7)
Abscess/aneurysm* 7 (41.2) 4 (6.7)
*p value for abscess = .118 *p value for aneurysm = .008
Echocardiographic features indicating a potential need for surgery were satisfied by at
least 90% (n=70) of the patients. There was frequent overlap of these features in some
patients (seven in the HIV positive, and fourteen HIV negative patients had an overlap
of these features) (table 11). There did not appear to be any differences between the
groups
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Table 11: Echocardiographic features predictive of surgery
Features HIV(+) n=17(%) HIV(-) n=60 (%) Total
Vegetations
Persistence after stroke 1 (5.9) - 1
>10mm 4 (23.5) 13 (21.7) 17
Increase in size - 1 (1.7) 1
Valve dysfunction
Perforated leaflets 1 (5.9) 1 (1.7) 2
Valve regurgitation 16 (94.1) 55 (91.7) 71
Impaired LV Function - 3 (5) 3
Not responding to antibiotics - 1 (1.7) 1
Paravalvular extension
Rupture/fistulae - 1 (1.7) 1
Abscess/aneurysm 7 (41.2) 4 (6.7) 11
4.6.8 H IV stage and Echocardiographic features
The mean CD4 count in the HIV positive patients was l 89/mm3 . Four HIV positive
patients had advanced immunodeficiency with a mean CD4 count <100/mm 3 (table 12).
To determine any association with the stage of infection the echocardiographic findings
were examined in the HIV positive patients, stratified into 3 groups: CD4 counts
<100/mm 3 ; 100 to 200/mm3 ; and >200/mm 3 . No striking differences emerged between
the groups. Three of the four patients in the group with AIDS had vegetations, and the
fourth, an aortic root abscess. Leaflet aneurysms were found in four patients all with
CD4 counts of >100/mm 3 . The commonest infecting bacterium was S. aureus, found in
four patients; all had CD4 counts between > 1 00/mm 3 .
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Vegetations n= 3 n=2 n=6








































Pericardial effusion 2 2 2




*p value for vegetation size = 0.739
4.7 Surgical Findings
Thirty-nine patients (thirty-four HIV negative and five HIV positive) underwent valve
replacement surgery. Fewer HIV positive patients had surgery since the decision to
operate was based on a CD4 count >200/mm 3 by the surgeon. At surgery the underlying
valve pathology was considered to be rheumatic in origin in thirty-seven cases (95%).
In the two remaining cases, the valves were normal.
The diagnosis of IE was confirmed at surgery in 28 out of the 39 cases yielding a high
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sensitivity for the modified Dukes, but a low positive predictive value (table 14). In the
remaining eleven patients the surgical findings ranged from fibrotic valves to chronic
rheumatic valvulitis. Evidence of active rheumatic valvulitis was present in seven
patients who also had infective endocarditis.
At surgery vegetations detected on echocardiography were confirmed in 23 out of 37
cases, yielding a sensitivity of 92% and a positive predictive value of 62% (table 13).
The detection of aneurysm (n=1/2), abscess formation (n=2/4) and leaflet / cuspal
perforations (n=1/7), was suboptimal with echocardiography when compared to the
findings at surgery. Echocardiography however, proved accurate in the diagnosis of
chordal ruptures, and the presence of a fistula.














Prevalence 0.64 [0.47, 0.78]
Sensitivity 0.64 [0.43, 0.81]
Specificity 0.00 [0.01, 0.27]
Accuracy 0.41 [0.26, 0.58]
Predictive value of +ve result 0.53 [0.35, 0.71]
Predictive value of -ye result 0.00 [0.01, 0.37]
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Table 14: Accuracy of Modified Duke Criteria in the diagnosis of Infective
Endocarditis using surgical findings as the gold standard
Modified Duke Criteria Surgery Total
Positive Negative
Positive 28 11 39
Negative 0 0 0
Total 28 11 39
Screening [95% CI]
Prevalence 0.72 [0.55, 0.841
Sensitivity 1.00 [0.85, 1.00]
Specificity 0.00 [0.01, 0.32]
Accuracy 0.72 [0.55, 0.84]
Predictive value of +ve result • 0.72 10.55, 0.84]
Predictive value of -ve result **** [****. ****]
Table 15: Accuracy of vegetation detection by echocardiography using the surgical
findings as the gold standard
Vegetations Sur er Total
Positive Negative
Positive 23 14 37
Negative 2 0 2
Total 25 14 39
Screening [95% CI]
Prevalence 0.64 [0.47, 0.78]
Sensitivity 0.92 10.72, 0.99]
Specificity 0.00 [0.01, 0.27]
Accuracy 0.59 [0.42, 0.74]
Predictive value of +ve result 0.62 [0.45, 0.77]
Predictive value of -ve result 0.00 [0.05, 0.80]
4.8 Surgical Outcome
In all patients medical therapy with appropriate antibiotics had been instituted and
continued for a total period of six weeks One patient, HIV positive, was referred for
emergency surgery. The remaining 38 had urgent surgery in the ensuing weeks. Three
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patients demised after surgery (one demised in theatre, one at day seven [HIV positive]
and one at day eight post surgery [see mortality below]).
Amongst the HIV negative patients, fifteen had impaired ejection fraction due largely
to paradoxical septal motion one week after surgery. At six weeks after surgery two had
significant prosthetic leaks and three patients showing impaired ventricular
contractility. At the six months follow-up visit one patient had a moderate leak, and two
had impaired ventricular contractility. One patient had a stroke nine months post
surgery, due to over anticoagulation. At two years follow-up, four patients had mild
prosthetic leaks, and one had impaired contractility of the left ventricle.
Amongst the HIV positive patients four had impaired contractility of the left ventricle
and one patient had a mild prosthetic leak one week after surgery. One patient demised
at day 35 post surgery. At six months and three years follow-up, there was
normalisation of the ejection fraction, and the prosthetic leak remained mild. There
were no instance of stroke.
4.9 Mortality:
Eighteen (23.4%) patients (fourteen HIV negative and four HIV positive) demised
during the course of the study. Six (7.8%) had chronic renal failure. Four of these
patients were receiving haemodialysis at the time of diagnosis.
Of the fourteen HIV negative deaths three died in the hospital shortly after surgery (at
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surgery, day 7 and day 8). At operation there was fibrinous material covering the
prosthetic valve with an aneurysm of the ascending aorta in one patient, severe aortic
regurgitation with and abscess and fistula formation in the second, and the remaining
patient had a valve completely destroyed by endocarditis, with a mass of vegetations on
the aortic valve. The patient who demised at surgery had occlusion of the coronary
ostia; the patient who demised on day seven was documented as cardiogenic shock, and
the last patient had an intraventricular haemorrhage. The remaining eleven patients died
after discharge from hospital. No exact cause of death could be determined.
Of the four HIV positive patients who demised, one died 35 days after surgery whilst in
hospital, as a result of methicillin resistant staphylococcal (MRSA) septicaemia,





This is one of the first echocardiographic studies of IE comparing HIV positive and
HIV negative patients in a cohort of seventy-seven patients seen over a three year
period (2004 to 2007). Few data have been published on the clinical characteristics and
outcome of IE in patients with HIV infection. Even fewer data exist on the
echocardiographic findings in these patients. To date, IE in HIV infected individuals
Western series has been described almost exclusively in intravenous drug users, and has
been reportedly rare in other HIV infected subjects. In this report we have described the
echocardiographic features of IE in HIV positive subjects and related them to the
clinical findings.
In contrast to Western series the most common underlying predisposing abnormality
observed in our study was rheumatic heart disease. The mitral and aortic valves were
predominantly affected, mostly by the presence of a single vegetation. Certain
differences emerged in that the size of the vegetations were slightly larger in the HIV
positive patients (11mm compared to 10mm of the HIV negative patients) (p = 0.447), a
finding that was more predominant in the patients classified as having AIDS. Leaflet
aneurysms and aortic root abscesses occurred more frequently in the HIV positive
patients, but the numbers are too few to draw firm conclusions.
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With the exception of fever which was significantly more common the HIV positive
patients (23.5%), the clinical profile of IF in the HIV positive patient was similar to the
HIV negative patient, and was characterized by clubbing, murmurs and severe valve
regurgitation. Echocardiography revealed severe valve damage, often with abscess
formation, consequent upon advanced infection. Although ventricular contractility, as
assessed by EF was similar in both groups, ventricular dimensions were increased
(albeit not significantly) in the HIV negative patients. This was associated with the
presence of pericardial effusions. Furthermore, more than half (62%) the patients with
pericardial effusion had failure of leaflet or cuspal coaption. These findings are in
keeping with the fact that HIV negative patients had a higher rate of overt heart failure.
None of the effusions were thought to be due to tuberculosis, although in one patient
(HIV negative) there was fibrin stranding within the effusion, with other evidence to
indicate tuberculosis.
5.1 Bacteremia:
S. aureus was the most common infecting bacterium (20.8%) found in this series,
followed by S. viridans (9.1%). Like Jaffe40, et al, in Seattle, Washington, these
organisms accounted for the majority of the culture positive cases. S. aureus was found
in four HIV positive (23%) patients, and twelve HIV negative (20%) cases in our series.
In a study similar to ours Abrahams 27 found that S. aureus was the causative organism
for bacteremia in almost half of all patients in both groups. These findings are in
contrast to a local series by Koegelenberg41 , et al, in the Western Cape, who showed
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that S. viridans is still the most common of bacteria in their group of HIV positive
patients.
In western series S. aureus is the most common causative organism causing IE in HIV-
positive patients; it is reported largely in intravenous drug users and had a predilection
for the tricuspid valve. None of the patients recruited in our study were intravenous
("mainline") drug users. Right-sided IE was found in five patients (6.8%, all HIV
negative) and occurred in those with congenital abnormalities (such as patent ductus
arteriosus and ventricular septal defects). The incidence of left-sided involvement with
S. aureus was similar in both HIV positive and HIV negative patients; it was found in
three (17.6%) HIV positive and nine (15%) HIV negative patients.
Petzsch2° suggests that persistence of S. aureus in the blood cultures should raise
suspicion of valve abscesses or possible metastases to other organs. Only one patient in
our study, who had multiple positive blood cultures, had a root abscess secondary to S.
aureus infection. Infective endocarditis due to S aureus is a fulminant infection
associated with higher rates of stroke, systemic embolization, persistent bacteremia, and
a high mortality (25% to 40%). 24 Six of our eighteen deaths were due to S. aureus
infection, (two HIV positive).
The majority of patients in our study had underlying rheumatic heart disease as a
predisposing factor. In five patients IE occurred in the setting of haemodialysis (n=4)
and pacemaker infection (n=1). The underlying valve morphology was thought to be
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normal in three patients with S. aureus infection; two were HIV positive and one was
HIV negative. None of the three (3.9%) patients with prosthetic valve endocarditis (all
HIV negative) had S. uureus infection. In all three cases the infection occurred long
after surgery (10yr, 10yr and 5 months) and was due to corynebacterium and
pseudomonas aeruginosa; the remaining patient had a negative blood culture. These
patients had peri-prosthetic leaks, but there was no evidence of other complications
such as ring abscesses, fistulae, conduction defects or purulent pericarditis. 9
We tried to ascertain whether the size of vegetations was related to certain groups of
organisms, and found that the majority of patients with vegetations >10mm were in fact
culture negative IE (n=12). The high rate (54.5%) of culture negativity in this series is
worrying and probably related to prior antibiotic therapy and poor culture techniques.
In this setting, the sensitivity of the Duke criteria is diminished, as it relies heavily on
microbiological indices. 16 In our study, forty-two patients had negative blood cultures,
an occurrence which is likely due to the setting of our study, which is a tertiary referral
centre receiving patients who arc already on antibiotics. In febrile patients with elevated
ESR clinicians at base hospitals feel obliged to administer antibiotic therapy prior to the
completion of a basic evaluation. Hence the large number of 'culture -negative' IE
cases.
41
 This has serious implications for treatment, especially in HIV positive patients,
since the ESR is often elevated from non-valvular infection. Recent literature suggests
that a marked reduction in the incidence of bacteremia is also seen in patients receiving
antiretroviral therapy. Only three patients in our study were on highly active
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antiretroviral therapy (HAART) treatment, and a positive blood cultures was found in
one of the three patients (S. aureus).
Cardiovascular disease patterns in HIV-infected people have been reported to be similar
in Europe, North America, and Africa. 42 The difference exists in the causative
organisms implicated in these conditions. 42 Bacteremia is common in patients who are
HIV positive and is due to the numerous immunologic defects present in this disease. 27
We did not find the unusual causative organisms reported in the West such as
barbonella, salmonella, and listeria, but we did have two instances of rare organisms,
(propionibacterium and corynebacterium).
5.2 Nonbacterial thrombotic endocarditis
Slightly more HIV positive patients in our study, ten (58.8% vs. 50%) were shown to
have negative blood cultures, thereby raising the possibility of nonbacterial thrombotic
endocarditis (NBTE) in these cases. Initially known as thromboendocarditis, NBTE
refers to the fibrin deposition on the cardiac valves.
43 
It is commonly found in patients
with a variety of malignancies, and is known to complicate fulminant acute diseases
such as septicemia or burns. 43 Underlying rheumatic heart disease is thought to be an
important aetiologic factor in NBTE.43 It is thought that both valvular deformation and
hypercoagulable states are important in the genesis of NBTE. 43 The deformed valve is
exposed to blood platelets, which adhere to collagen, resulting in nonbacterial
thrombotic vegetations, with an absence of inflammatory reaction. 43 Direct valvular
damage could lead to verrucae formation.43 It is said that the presence of vegetations
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with a noninfectious aetiology can also produce a clinical picture similar to that of
culture-negative endocarditis. Although large embolisation associated with NBTE is
rare
 I
, small embolisation is more frequent as the vegetations are assumed to be quite
friable and embolise easily43 . There are no particular symptoms and signs, which
suggest a diagnosis of NBTE, but serial negative blood cultures should alert the
clinician to the possibility of NBTE which is reportedly common in HIV positive
patients. 41 . Neurological events are the most common manifestation of NBTE. 43 Of
interest, three of our HIV positive patients had strokes, (two culture negative) thereby
suggesting the possibility of NBTE in the latter cases. Because of the absence of an
inflammatory reaction in NBTE a low rate of positive rheumatoid factor levels is
expected. In our study we did have a lower rate, 23.4% (n=4) in HIV positive,
compared to 55% (n=33) in the HIV negative patients. In one HIV positive patient, who
had a CD4 count >200/mm 3 , we found a "vegetation" along the free wall of the left
atrium, below the left atrial appendage. This was not thought to be a thrombus, because





5.3 Role of echocardiography in IE
5.3.1 Vegetations
Vegetations were found in 88.3% (n=68) of our patients. They were attached to the
heart valves, chordae or the mural endocardium and were also found in association with
septal defects. Vegetations on the mitral and aortic valves were found to occur with the
same frequency in both HIV positive and negative patients. Vegetation size was
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slightly bigger in the HIV positive patients (11mm versus 10mm in the HIV negative
patients) (p = 0.447). Patients with CD4 counts <100/mm 3 , were shown to have larger
vegetations (14mm) than the remaining HIV positive patients (1 lmm) (p = 0.739).
It is said the absence of echocardiographically visualised vegetations identifies patients
with lower morbidity and mortality, since these patients are likely to have fewer
embolic events, less congestive heart failure, and require surgery less frequently. In our
study we found that only one HIV positive patient who had no endocardial
involvement, but six HIV positive patients had extensive valve damage from the
infective process without vegetations. It is possible that in these cases vegetations may
have embolised. The total disappearance of vegetations has been previously observed in
a study by O'Brien45 , et al during the treatment period, without clinical evidence of
systemic embolization. We noticed this in one HIV positive patient in our study, who,
at day 41, showed a disappearance of the vegetation. In another patient (HIV negative)
the vegetation appeared smaller and denser on the echocardiogram after one month of
medical treatment. Serial evaluation of changes in vegetation size and morphology
depends on the ability of the observer to reproduce both transducer position and gain
setting, so that the size and density data may be compared. 45 By increasing the gain
setting it is possible to make a lesion appear larger, and vice versa. 45 Proper
standardization of technique is an important aspect in evaluating the natural history of
vegetations.45 This has clinical significance since a vegetation has to be 2-3mm before
it can be detected by the imaging system.
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The high rate of negative blood cultures raises the possibility that vegetations were the
result of disease processes other than infection. Therefore clinical correlation with
echocardiographic findings is necessary, since echocardiography (both TTE and TEE),
is unable to differentiate between septic and aseptic vegetations such as that seen in
NBTE, neither is it able to distinguish between present and past infection. 48 The
verrucae of rheumatic carditis could also be the cause of false-positive findings when
small vegetations are detected at echocardiography. Indeed many of our patients were
young (fourteen of the patients were below twenty years of age), and could have had
recrudescent rheumatic carditis. This accounts for the fact that histological evidence of
carditis was present in seven of the thirty-nine patients who had valve replacement
surgery.
Several studies 15 ' 36 ' 38 , et al, have shown a higher complication rate, particularly stroke,
in patients with vegetations over 10 mm. Of the nine patients who had a stroke in our
study, only one was found to have vegetations over 10mm in size. Among the risk
factors associated with embolic events (age, vegetation size, prothrombin activity,
serum albumin, and CRP) 46 we noted an elevated CRP level in our patients who
developed strokes. CRP has been shown to be an important marker of bacterial
infection, and also possible complications in patients with IE. 46 It is thought that CRP
induces the inflammatory response, with direct effect on platelets, thereby resulting in
more friable lesions that are at risk for embolization. 46 Caball's study showed no
correlation between vegetation size and cerebral embolisation 46 and he therefore
suggested that an elevated CRP is independently associated with thromboembolic
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events The highest CRP levels in our series were documented in two HIV positive
patients with stroke (135 and 142mg/L).
Cabell46 , et al, have reported that at least 37% of patients with definite 1E demonstrate
evidence of thromboembolic events. Embolisation can occur before the diagnosis of 1E,
during therapy, and after therapy is completed. 24 In our study seven patients were
referred with stroke, one patient experienced a stroke while on treatment, and another
had a stroke post surgery. These nine accounted for 10.4% with a clinically overt
embolic episode, all on native valves; three were HIV positive. Baddour 24, et al
suggests that there is an increased incidence of embolisation amongst patients infected
with S. aureus, Candida, (Haemophilus parainfluenzae, Haemophilus aprophilus,
Actinobacillus actinomycetemcomitans, Cardiobacterium horninis, Eikenella corrodens,
Kingella kingae, sutonella) HACEK and abiotrophia organisms. We isolated S. viridans
in two of the nine patients with stroke. We did not routinely perform CT scans on our
patients, and so cannot comment on the prevalence of occult cerebral embolisation.
Computerised tomographic (CT) scans (n=14), showed infarcts in half (n=7), brain
atrophy in four, and in the remaining three found no abnormalities. Two of the patients
were HIV positive, and were shown to have brain infarcts, both of whom had strokes.
None of the patients in our study had evidence of mycotic aneurysms, which has been




Pericardial effusion (PE) was a common finding in both groups in this study and was
attributed largely to heart failure. A higher rate of pericardial effusions was seen in the
HIV negative patients, twenty-six HIV negative (43.3%) patients compared to six HIV
positive patients (35.3%). Twenty-two patients in the HIV negative group had advanced
valvular insufficiency, with associated heart failure seen in twelve cases, versus two of
the six HIV positive patients with PE. Pericardial effusions are considered to be a
common form of cardiovascular involvement in HIV infected individuals, the cause of
which includes S. aureus, as a result of endocarditis. 39 Recent reports show that
pericardial effusion is associated with a low CD4 cell count, and is a marker of end-
stage HIV infection. In our study pericardial effusions were seen in six out of the
seventeen HIV positive patients, and the average CD4 count in these patients was
166/mm3 . Two of the four AIDS patients had PE, one associated with heart failure and
one had a tuberculous aetiology.
5.3.3 Complications in 1E:
We looked carefully for evidence of complications, defined as the presence of
congestive heart failure, new valvular regurgitation, refractory infection, systemic
embolization, or valvular vegetations. 47 ' 42.9% (n=33) of our patients had heart failure,
and nine (11.7%) had strokes, three of whom were HIV positive. Large vegetations
(>10mm) were seen overall in seventeen patients (22.1%), (four were HIV positive)
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Furthermore, early diastolic closure of the mitral valve is an indication of an unstable
haemodynamic status." One of the patients in our study were shown to have early
closure of the mitral valve on the echocardiogram, in the presence of acute aortic
regurgitation, an indication of severe haemodynamic sequelae, which according to
Evangelista", et al. is likely to precipitate heart failure. In this patient there was
premature closure of the mitral valve in the presence of severe aortic regurgitation. The
patient had an aortic root abscess, a 1.4cm vegetation, with a sinus of valsalva fistula.
Perivalvular complications leading to leaflet perforation and flail leaflets, was seen in
three patients. Perivalvular extension of the infection with abscess formation and the
development of fistula has a poor prognosis." Six aortic root abscesses were found in
our study, all in native valves (three HIV positive, and three HIV negative patients).
These abscesses were larger in size in the HIV positive patients (0.73cm depth x 1.2cm
width vs. 0.3cm depth x 0.45cm width). We also found total of five aneurysms at TTE
in the study. Two of these were cuspal aneurysms of the aortic valve, both of whom
were in the HIV positive group. The remaining three aneurysms were located on the
mitral valve, two of which were in the HIV positive patients. One leaflet aneurysm was
found along the annulus of a mitral prosthesis in an HIV negative patient, confirmed at
TEE. The leaflet aneurysms, like the aortic root abscesses were larger in the HIV
positive patients, (0.86cm depth x 0.85cm width vs. 0.21cm depth x 0.3cm width).
Expansion of the abscess cavity with pseudoaneurysm formation resulted in perforation
and fistulous connection to the right atrium in an HIV negative patient. In aortic
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endocarditis the regurgitant jet is directed onto the mitral-aortic intervalvular fibrosa,
leading to spread of the infection along the anterior mitral leaflet. 48 Infection of the
mitral valve secondary to aortic valve infection in this way was found in eleven
(14.3%) patients in our study. Maintaining the morphological and functional integrity
of the mitral valve apparatus requires early detection of the spread of infection so that
timely surgical intervention may enhance preservation of the valve. 49 Here the
echocardiographer has an has an important role in defining the extent of infection and
identifies the risk of extension to the rnitral valve.
5.3.4 Diagnostic criteria in Infective Endocarditis:
In 1994, D.T. Durack proposed a set of diagnostic criteria for the diagnosis of IE, which
became known as the Duke criteria. 50 Prior to the Duke criteria, the Beth Israel criteria
were the only recognised diagnostic criteria for IE. 34 Although the Duke criteria have
incorporated echocardiographic findings, major diagnostic weight was given to three
typical findings, which are: mobile echodense mass/masses seen attached to valvular
leaflets; periannular abscesses; and new dehiscence of prosthetic valves. 24 The Duke
criteria recognise the high sensitivity and specificity of echocardiography in detecting
vegetations, and therefore included this tool as a major criterion.4 Classification criteria,
prior to the Duke criteria, did not include echocardiography, and proved to be of limited
value when blood cultures were negative. 19 Although the sensitivity and specificity for
the Duke criteria has been validated, several shortcomings of this schema remain. 50
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Limitations of the Duke criteria lie in the misclassification of 'possible' endocarditis,
thereby yielding a sensitivity of only 76%. 16 Modifications to the Duke criteria have
included S. aureus bacteremia as a major criterion, with the addition of minor criteria
such as splenomegaly, splinter hemorrhages, petechia, newly diagnosed clubbing,
elevated ESR, elevated CRP levels, the presence of central non-feeding lines, peripheral
lines, and microscopic haematuria. 5° Li et al have proposed that vascular phenomena
should remain a minor criterion as numerous febrile patients with stroke, vasculitis, or
rickettsial disease could be erroneously classified as 'possible IE'. 5°
In our study the modified Duke's classification was used. When compared to surgery
the positive predictive value of the modified Dukes is only 72%, highlighting the
difficulties in using this classification in the absence of positive blood cultures.
Incorporation of the inflammatory markers into the criteria decreases the 'possible'
cases from twenty-three in the original Dukes to nine with the modified Dukes criteria
and increases the 'definite' cases from sixty-three in the original Dukes to seventy-
seven with the modified criteria (table 1), without any change in the 'rejected' cases. A
deficiency in the modified criteria becomes apparent when diagnosing IE in the HIV
population, as these patients often have elevated ESR and CRP levels which is likely
due to non-cardiac infection. Therefore, using these additional minor criteria could
result in a higher rate of false-positive diagnoses of IE, particularly in the absence of
positive blood cultures. Adding additional minor criteria upgrades the classification of
IE from 'possible' to 'definite', and with a resultant increase in false positive diagnoses




A principle limitation of echocardiography is that it is unable to reliably differentiate
between active and healed endocarditis. 9 Healed vegetations have been characterized on
echocardiography as an indentation of the free margin of a cusp. (identifiable on TEE),
possible perforation of the body of the cusp with thickened edges, cuspal aneurysms,
ruptured chordae tendineae, and healed fistulae. 9 In the majority of patients in our study
we could detect no appreciable differences in the appearance of vegetations at the
echocardiography after one month of treatment. Calcified healed vegetations were seen
in three HIV negative patients. One HIV negative patient showed a reduction in the
vegetation size after one month of treatment with antibiotics. In another case (HIV
positive) repeat echocardiogram showed complete disappearance of a vegetation
confirmed on TEE, after five weeks of antibiotics. No clinical evidence of embolisation
was documented. The natural history of vegetations could not be determined in this
study because of the fact that most patients discharged did not return for follow-up. A
sobering finding in this evaluation was the over-diagnosis of vegetations at
echocardiography, even with the use of TEE.
5.3.6 Surgery in IE:
Surgical intervention is warranted in severe valvular insufficiency associated with heart
failure unresponsive to medical therapy, and valve related complication. 24 In the group
as a whole, congestive heart failure (CHF) was the most common indication for surgery
60
(n=10), progressive worsening of valvular insufficiency (n=33), and ventricular
dysfunction (n=1), the mortality of which is dramatically reduced by surgery, especially
in the presence of aortic regurgitation. 24 Overall, thirty-three patients in the study had
CHF, three had echocardiographic evidence of ventricular dysfunction, and more than
two-thirds (n=71) had severe valvular insufficiency at the echocardiogram. CHF may
develop from native valve perforation, chordal rupture, and valvular obstruction by the
presence of large vegetations, sudden intracardiac shunts due to fistulous tracts or
prosthetic dehiscence. 24 In the patients who had have positive blood cultures, the mitral
valve (n=19) was more frequently involved compared to the aortic valve (n=14).
Further analysis showed the mitral to be the most frequently affected valve in the
patients with CHF, in both the HIV positive (four of nine patients with CHF) and the
HIV negative (nine of twenty-one with CHF). None of the patients had acute aortic
regurgitation with acute heart failure; this was evident in the average size of the
ventricular dimensions. 24
Echocardiographic features that suggested the need for surgical intervention included a
persistent vegetation after systemic embolization, especially those of the anterior mitral
leaflet with a size of >10mm, and an increase in the size of a vegetation despite
antimicrobial treatment, also paravalvular extension of the infection, and valvular
dysfunction. 24 These features were seen in approximately 90% of the patients in our
study, although there was an overlap of lesions in twenty-one patients (seven of whom
were HIV positive).
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We defined a poor surgical outcome by the development of stroke, prosthetic valve
leaks or a reduced ejection fraction, which was seen in fifteen of the thirty-nine patients
who had surgery. Although Baddour24 et al noted a poor surgical outcome in patients
with CHF, renal insufficiency and advanced patient age, this was not a finding in our
study. Ten patients were seen to have impaired ventricular function post operatively, of
which, four had leaks across the prosthetic valves (three were mild leaks, two were
paravalvular leaks, and the third was a central leak; the fourth was a mild to moderate
leak), and one had a stroke. Twelve of the thirty-nine patents referred for surgery (one
HIV positive and eleven HIV negative) had features of heart failure prior to surgery.
One patient was also shown to have an impaired ventricular function of 35%.
Surgery revealed evidence of IE in thirty of the thirty-nine patients who had definite
endocarditis. The underlying pathology was chronic rheumatic valvulitis (with features
of endocarditis) in thirteen patients and interestingly seven had acute valvulitis.
5.3.7 Surgery in HIV:
Although valve replacement surgery may be life saving for some patients with active
endocarditis, the difficulty lies with deciding which patients should undergo surgery. 47
This has become more difficult in HIV positive patients as reflected in the fact that only
five of seventeen patients who tested positive were submitted to surgery. Despite the
fact that 90% of patients had features suggesting the need for surgery only 39
underwent valve replacement. Of the thirty-nine patients in the study who received
surgical intervention only five were HIV positive. According to Blyth 51 , et al, surgery
in patients with active IE, who are HIV positive, is associated with a significant
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mortality rate. CD4 counts >200/u1 are acceptable for surgery, however, counts of
400/u1 and above are more likely to he associated with a better outcome. 51 Blyth
suggests that surgery in HIV positive patients with an acceptable CD4 count is likely to
have a similar early outcome when compared with the HIV negative patients. 51
Successful treatment of IE relies on the ability of antibiotics to kill bacteria in situ,
rather than on host defences, which probably explains why IE is not more frequent in
i mmunocompromised patients. Identifying patients who are at high risk is important
because these patients require close monitoring. 40 Surgical intervention in these patients
is aimed at eradication of the infection, and correction of any haemodynamic
abnormalities. 24 Understanding how and when to intervene surgically is central to the
outcome of operation with reduction in mortality. Here again the skill and experience
of the echocardiographer is important in defining the complications warranting early
surgical intervention. One of three HIV positive patients who had reduced ventricular
function demised after surgery compared to three deaths among the fifteen HIV
negative patients with reduced ventricular function. Like Barbaro 33 we feel that HIV
infection is not a contraindication to cardiac surgery, and is not clearly associated with
an increase in the postoperative complication rate or increased mortality. However, the
overall impression is that the hospital morbidity and mortality rate in this group of
patients is higher than most groups. 52
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5.4 Outcome
According to Katz39 , et al, past studies have shown no difference in the presentation of
IE, or the survival of patients with IE who are HIV positive. The difference however, is
presumably seen in the late stage of HIV infection, where the mortality among HIV
infected patients is supposed to be markedly increased. 39 According to Monseuz53 , et al,
non-survival of patients depends on two factors: clinically overt cardiac disease, and
having AIDS rather than AIDS—related complex, and it is assumed that cardiac
symptoms are less likely to be present in patients with AIDS—related complex. We
found a similar rate of morbidity and mortality in the HIV positive and HIV negative
patients. There were four known deaths amongst the HIV positive patients (23.6%), and
fourteen deaths amongst the HIV negative patients (23.3%). Four of these patients
demised after surgery. The remaining patients demised either during admission at our
hospital, or at their respective referring centre. Of the known HIV positive patients
from our study who demised, none had CD4 counts <100/mm 3 , in keeping with the data
from Fowler, et al, who found that overall morbidity and mortality related to cardiac
disease in AIDS is low. 54
5.5 Study limitations:
The small sample size of the study was a limiting factor. This could be due to the poor
referral system from the base hospital to our hospital, or in fact, that IE is not as
common in HIV positive patients as we had presumed. Also not all patients diagnosed
with IE at TTE received a TEE. This was due to various reasons such as a patients'
inability to tolerate the TEE probe and elevated international normalized ratio (INR)
64
levels at the time of examination. A further limitation in the study was the high rate of
negative blood cultures. This was most likely the result of administration of antibiotics
to the patient prior to referral to our institution, or in the case of the HIV positive
patient the possibility of NBTE.
Of the 91 patients initially screened, 77 were accepted as having had a 'definite'
diagnosis of IE according to the modified Duke criteria. The remaining 14 were deemed
not having IE and excluded from analysis. Whether any patients in this group had IE or
not (true negative and false negative) could not be determined with certainty since they
were not subjected to surgery. We believe the modified Dukes criteria were responsible
for the higher false positive rates since it permits diagnosis of IE based on the
echocardiographic criteria in the absence of positive blood cultures. While this reflected
a potential flaw in the study, since the diagnosis of infective endocarditis was based on
the finding of vegetations in the absence of positive blood cultures, (yielding a
sensitivity of 100% and a specificity of 0% for the detection of vegetations), this study
highlights the difficulty in diagnosis when the blood cultures are negative, placing more
reliance on the detection of vegetations. We have done a further analysis on Table 13
(page 42) showing that echocardiography had overdiagnosis of vegetations and
underdiagnosis for the detection of the other structural abnormalities related to infective
endocarditis.
Unless supported by clinical features and bacteriologic evidence, vegetations alone are
not diagnostic of IE because they may represent healed infection." It is known that
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vegetations may persist long after bacteriologic cure. 55 The diagnosis of IE
postoperatively, is rendered more difficult by the now common practice of leaving the
chordal mechanisms intact. Five of the thirty-three patients clinically diagnosed as
`definite' IE, and one 'possible' IE, had no evidence of infection at operation,
supporting the need for bacteriological confirmation of infection.
Not all patients however were referred for surgery. The low CD4 counts in the HIV
positive patients meant an even smaller group of these patients were accepted for
operation, as the acceptable CD4 level for surgery at our institution is >200/mm 3
In this study attempts were made to define the valve pathology on echocardiography
more accurately. According to Taams, et al, there are five distinct pathological features
of IE that may be seen clearly on TEE and these are (1) mitral stenosis with vegetations;
(2) myxomatous degeneration of leaflets with vegetations; (3) chordal rupture with
vegetations; (4) chordal rupture without vegetations; and (5) mycotic aneurysms with
fistulous connections. 38 It is often difficult to decide on the underlying pathology with
this degree of accuracy with transthoracic imaging (TTE). In our study harmonic
imaging (HI) was employed to improve the diagnostic value of TTE by improving the
image quality, as documented by Chirillo 35 , et al. Harmonic imaging works on the
principle of limiting near field artefacts, and because the harmonic energy increases
with the distance the ultrasound wave propagates most harmonics will result from the
central ultrasound beam rather than the weaker side lobe artefacts. 35 This modality is
used primarily to enhance left ventricular endocardial borders. Its use did not really
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increase the resolution in visualizing vegetations. Therefore, we used TEE to
differentiate and define chordal rupture in association with vegetations, leaflet prolapse
and flail leaflets. Our surgical findings reveal that even within TEE there were





Over a three year period we analyzed ninety-one patients with IE, of whom seventy-
seven were diagnosed as having definite IE at a tertiary referral centre in KZN. There
was a high morbidity and mortality in the group as a whole because of the late
presentation of these patients. The study calls for a careful evaluation of patients with
suspected IE, since the final diagnosis at surgery could only be confirmed in 72% of
cases using the modified Dukes criteria. Although literature states that modern
echocardiography has an increased specificity for detecting vegetations, this study
clearly indicates the limitations of relying on echocardiography alone to make a
diagnosis of IE and draws attention to the importance of blood cultures in diagnosis.
Overall, the study showed no significant increase in the complication rate as seen
echocardiographically, in the HIV positive patients. Certain lesions, such as leaflet
aneurysms and root abscesses did appear to be more frequent, and were of a larger size
when compared to the HIV negative patients, but were not related to the stage of HIV
infection. Vegetations were also a larger size in the HIV positive patients with CD4
counts <100/mm 3 .
In the West IE is a severe illness seen in intravenous drug users with or without HIV
infection. Patients with HIV infection are at increased risk of bacterial infection, and it
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is thought that the more advanced stages of immunodeficiency modifies the clinical
course and increase the severity of bacterial infection. In fact Koegelenberg found that
S. viridans was still the commonest organism in his series. Many of the findings in our
study were similar to the study by Koegelenberg
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, but our pathogen profile was
different and we had a high culture negativity rate.
The commonest infecting organism in our series was S. aureus, followed closely by
S. viridans. The high rate of culture negative endocarditis was a serious limitation to the
study, and was most likely the result of prior antibiotic therapy. The presence of NBTE
in culture-negative cases could not be determined with certainty. However with the
increased levels of serum CRP and the underlying valvular stenosis found in four HIV
positive patients, there is a possibility that they could have had NBTE.
There have been few studies that have prospectively examined IE in HIV subjects,
except for subgroup analysis of smaller numbers of subjects with IE. In this series IE
was not as common as expected. It is estimated that at least 4% of these will develop
cardiac complications. 29 In our study the overall rate of complications was 50.6%, of
whom 17% were HIV positive. In contrast to the Western series we did not identify
intravenous drug abuse as a risk factor but rheumatic heart disease remains as an
important predisposing factor for developing endocarditis. With the increasing drug
abuse, the prevalence of endocarditis in HIV will likely increase, posing problems in
detection and management. Improved culture techniques are important to detect the
causative organism, since this remains a major criterion in the diagnosis of IE in
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developing countries where rheumatic heart disease is endemic and repeated infection
common. Considerable skill is needed in differentiating vegetations from damage due
to previous infection disease or to rheumatic carditis, and in differentiating vegetations
from damaged chordal apparatus which is frequent in patients with valvular disease.
Further more patients with HIV infection already have elevated ESR and CRP and






PATIENT INFORMATION LEAFLET AND INFORMED CONSENT




Echocardiographic features of the complications of Infective Endocarditis with special reference to
patients with HIV.
Introduction:
You are invited to volunteer to participate in a research study. This information leaflet is to help you
decide if you would like to participate. Before you agree to take part in this study, you should fully
understand what it entails. If you have any questions that are not fully explained in this leaflet, do not
hesitate to ask. You should not agree to take part unless you are completely happy about all the
procedures involved.
What is the purpose of this study?
1. To investigate the complications of Infective Endocarditis.
2. To assess how common the complications of Infective Endocarditis is in patients with HIV.
You have been diagnosed with Infective Endocarditis, and therefore, we would like you to consider
taking part in this study.
What is Infective Endocarditis?
Infective Endocarditis is inflammation of the inner lining of the heart.
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What is the duration of this study?
A minimum of 60 subjects will be in the research, the duration of the study per subject will depend on the
duration of their treatment, followed-up to their period of recovery (+/- 6 weeks). The entire study will be
completed in 2 years.
What does involvement in the study entail?
1. If you agree to participate in the study, you will be seen by doctors in the ward / clinic / CCU.
2. Once diagnosis of Infective Endocarditis has been done, you will have a few blood tests. This will
include a test for HIV. Counseling, by appropriately qualified personnel at IALCH, will be offered to you
before and after the HIV test, provided you have not been already tested and counselled at your base
hospital.
3. You will then have an echocardiogram. This involves coming to the Echo Lab, lying on a couch, a
small amount of gel placed on your chest, and an ultrasound probe placed over the gel. This is done in
order to perform a study of your heart valves.
It may be necessary to make further assessment of your valves in detail using a transesophageal probe.
This involves passing an ultrasound probe / a tube (this is twice the size of a pen) through your throat,
and you will be required to do is swallow the probe.
Has the study received ethical approval?
The study protocol was submitted to the Nelson R Mandela Research Ethics Committee, and approval
has been granted by that committee. The study has been structured in accordance with the Declaration of
Helsinski (2000), which deals with research involving human subjects.
What are my rights as a participant in this study?
Your participation in this study is voluntary, and you may refuse to participate, or stop at any time,
without stating your reasons for doing so. Refusing to participate in the study, or withdrawing, will not
affect the medical care you receive at this institution; you may also be withdrawn from the study, if it
thought to be in your best interests.
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What are the risks involved in this study?
There is a minimal risk in experienced hands, in patients with an intact mucosa, and a normal esophageal
wall, with no infections. However, there is an increased risk in a small percentage of patients who have
mucosa] insults, or perhaps weakened esophageal walls which could perforate, gastric ulcers, esophageal
varices, and strictures, but, every effort is made to exclude these before the procedure is carried out.
Further risks include trauma to the teeth and gums, trauma to the oropharynx, and any risks associated
with the agents used for sedation of the patient. Rare complications such as esophageal tears may
possibly cause perforation of the esophagus, or stricture formation. Minor trauma, e.g trauma to gums,
will be managed with observation, and the patient will be kept nil per mouth for 24 hours. Major trauma,
e.g esophageal tears, will be managed with investigative x-rays, such as contrast swallows, enlisting the
help of ENT, and the surgeons to determine whether surgery is an option. However, transesophageal
echocardiography is considered to be a low-risk procedure for infective endocarditis.
Source of additional Information
For the duration of this study, you will be under the care of the Cardiology Unit at IALCH. The
telephone number is 204 1746 / 1736, through which you can reach Dr M.Mbizeni, Sister W. Tobias, or
Miss S.Nel. The Research Ethics Committee Administrator, Mrs C. Bon -esen can be contacted at the
following telephone number should you have any queries regarding the ethical aspects of this study,
(031) 260 4416.
Confidentiality
All the information obtained during the course of this study is strictly confidential. Reported data will not
be including information that identifies you as a patient in the study. You will be informed of any finding
of importance to your health, and the information only disclosed to the above mentioned persons.
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INFORMED CONSENT
1. I hereby confirm that I have received and understood the Patient Information leaflet
2. I am aware that all information will be kept strictly confidential, and the persons who will be informed
about my HIV status are the doctor, ultrasonographer and attending professional nurse
3. I may at any stage withdraw my participation from this study, without any prejudice
4. I am prepared to participate in this study
Patient sign: Date:
Patients guardian (if applicable)
Sign: Date:






IPHESHANA LOLWAZI KANYE NEMVUME YESIGULI:
(Isiguli ngasinye kumele samukeliswe ipheshana, bese silifunda siqonde okuqukethwc ngaphambi
kokuba kuqale ucwaningo)
Izinhlamvu zokuqala zamagama akhe(initials):
Inombolo yobamba iqhaza:
ISIHLOKO SOCWANINGO:
Izimpawu zezinkinga ze Infective Endocarditis ezibonwa kwi Echocardiogram, ikakhulukazi esigulini
esinesandulela ngculazi.
ISINGENISO:
Uyacelwa ukuba ubambe iqhaza ocwaningeni ngokuzikhethela. Inhloso yaleli pheshana elinolwazi
wukuthi likusize ukuthatha isinqumo uma uthanda ukubamba iqhaza. Ngaphambi kokuba uvume
ukuzimbandakanya kulolu cwaningo, kumele Nonde kahle ukuthi liquketheni. Uma unemibuzo
engaphendulekanga ngokugcwele kuleli pheshana, ungangabazi ukubuza. Ungalokothi uvume ukubamba
iqhaza tuna ungakhululekile ngokuphelele ngemigomo ezolandelwa kulolu cwaningo.
YINI INHLOSO YALOLU CWANINGO
1.Ukucwaninga ngezinkinga ezibangwa wukuhlaseleka kontwentwesi olungaphakathi lwenhliziyo
okubizwa ngokuthi yi-Infective Endocarditis
2.Ukuhlola ukuthi zivame kangakanani izinkinga ezidalwa yi-Infective Endocarditis ezigulini
ezinesandulela ngculazi.
Utholwe une-Infective Endocarditis, ngakho-ke singathanda ukuba ucabange ngokubamba iqhaza kulolu
cwaningo.
YINI I - INFECTIVE ENDOCARDITIS
I-Infective Endocaditis- ukuvuvukala kontwentwesi olungaphakathi lwenhliziyo.
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LUZOTHATHA ISKHATHI ESINGAKANANI LOLU CWANINGO
Lolu cwaningo luyodinga abantu abangamashumi ayisithupha. Isikhathi sokuphela kocwaningo
kuyoncika esikhathi sokwelashwa kwabo, okuyolandeleka esikhathini abasinda ngaso (okungaba
ngaphezulu noma ngaphansi kwamasonto ayisithupha). Selulonke ucwaningo luyoqedwa esikhathini
esingangeminyaka emibili.
NGAKUBE UKUZIBANDAKANYA KULOLU CWANINGO KUQUKETHENI?
LUma uvuma ukubamba iqhaza kulolu cwaningo uyobe uhlolwa ngodokotela egunjini leziguli noma
emtholampilo noma e-CCU
2.Uma ukuhlolwa kwe-Infective Endocarditis sekuphelile, uyobe usuhlolwa igazi izikhathi ezimbalwa.
Lokhu kubandakanya nokuhlolelwa isandulela ngculazi. Uyonikwa izeluleko ngabeluleki abasezingeni
eliphezulu base-IALCH, ngaphambi nangernuva kokuhlolelwa isandulela ngculazi, ngaphandle uma
ungazange uhlolwe futhi unikezwe iziyalo esibhedlela sangakini.
3.Uyobe usuwenziwa i-echocardiogram okusho ukuhlolwa kwezinhliziyo ngemishini ehlola ingaphakathi
lomzimba ("emafutheni"). Lokhu kubandakanya ukuza kwakho elebhu, ulalilwe ohlakeni, kufakwe
imbijanyana yejeli esifubeni sakho, bese kuthathwa umshini ubekwe phezu kwayo. Lokhu kwenzelwa
ukuthi kuhlolwe izivimbo zegazi enhliziyweni yakho. Kungenzeka kube nesidingo sokuba kuphindwe
kuhlolisiswe izivimbo zenhliziyo yakho ngokujulile ngomshini obizwa ngokuthi yi-transesophageal
ECHO lokhu kubandakanya ukufaka emphinjeni ithumbu lokuhlola ngaphakathi (elinobukhulu
obuphindwe kabili kobepeni), wena okufancle ukwenze ukuba uligwinye leli thumbu.
NGABE LOLU CWANINGO LUGUNYAZIWE YINI NJENGOLUFANELEKILE NA?
Imigomo elawula lolu cwaningo yethulwa phambi kwekomiti i-Nelson R. Mandela Research Ethics
Committee, layamukela. Lolu cwaningo luhlelwe Iwahambisana ne-Declaration of Helsinski (2000),
okuyiyo ebhekcle ucwaningo okusetshenziswa abantu kulo.
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YIMAPHI AMALUNGELO ENGINAWO NJENGOBAMBA IQHAZA KULOLU CWANINGO?
Ukungenela kwakho lolu cwaningo kungokuzikhethela, futhi uma uthanda unganqaba ukulungenela,
noma uhoxe noma ngasiphi isikhathi ngaphandle ngokuthi uze ubeke izinkinga zokwenze njalo.
Ukunqaba okanye uhoxa kulolu cwaningo ngeke kuze kuthikameze ukwelashwa kwakho okuthola kulesi
sikhungo. Usengahoxiswa futhi kulolu cwaningo uma kukhona isidingo.
YIBUPHI UBUNGOZI OBUKHONA KULOLU CWANINGO
Buncane ubungozi obungaba khona kulabo asebejwayele, ezigulini ezine-intact mucosa futhi ezingenayo
inkinga emphinjeni yazo. Nokho-ke kunokwenyuka kancane kwezinga lobungozi ezigulini ezinenkinga
yontwentwesi noma ukukhathala kontwentwesi lomphimbo okungadala izilonda nenkinga yokugwinya
nokuvaleka kwamapayipi wokugwinya (oesophageal strictures), nokho-ke iyenziwa imizabo yokukhipha
bonke laba ngaphambi kokuthi kuqalwe. Obunye ubungozi bubandakanya iminjunju emazinyweni
nasezinsinini kanye nasemankankeni, nanoma yibuphi ubungozi obunobudlelwane bokusetshcnziswa
kwezidakamizwa ezisetshenziswa esigulini. Enye inkinga engajwayelekile enjengobuhlungu obuvuthayo
emphinjeni obubanga kube nzima ukuphefumula, kubange nokuphalaza okukhalisa izinyembezi.
Ukuhlukumezeka okuncane, isibonelo, ubuhlungu bezinsini kungabhekisiswa, kanti futhi nesiguli
singaqashelwa amahora angu-24. ukuhlukumezeka okukhulu, isibonelo, ubuhlungu obushisayo esifubeni
obuholela ekuphalazeni obukhalisa izinyembezi kona kuyohlolwa ngemishini yase-X-ray ukubheka
ushintsho ekugwinyeni, ukusiza nge-ETN, nokuthi odokotela babone ukuthi ngakube isejari iyona yini
engaba yisixazululo. Nokho-ke indlela yokuhlolwa kokushaya kwenhliziyo ebizwa ngokuthi yi-
transesophageal echocardiagraphy kuthathwa njengobungenabo ubungozi bokuhlola ukuhlukumezeka
kwenhliziyo.
LAPHO OKUNGATIIOLAKALA KHONA OLUNYE ULWAZI
Uma usengaphansi kwalolu cwaningo uzobe unakekelwe ngabakwa-Cardiology Unit e-IALCH.
Inombolo yocingo u-204 1746/1736, lapho ungathola khona u-Dkt. M. Mbizeni, Sister W. Tobias, noma
uNksz. S. Nel umphathi weKomiti lezokucwaninga Research Ethics Committee (031) 260 4416, uNkk C.
Borresen angatholakala kule nombolo uma unemibuzo mayelana nokwemukeleka kwalolu cwaningo.
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UBUMFIHLO
Lonke ulwazi olutholakale ngalolu phenyo luyimfihlo. Umbiko ngalolu phenyo ngeke ulufake ulwazi
olukuvezayo njengesiguli.Uyokwaziswa ngakho konke okubalulckile okutholakele mayelana nempilo
yakho, lolo Iwazi luyodalulwa kuphela kulabo ababalwe ngenhla.
IMVUME EKHULULEKILE
1.Ngiyavuma ukuthi ngilitholile ipheshana lesiguli elinolwazi futhi ngakuqonda konke okumayelana
nesiguli.
2.Ngiyazi ukuthi lonke ulwazi luyogcinwa luyimfihlo, nokuth abantu abayokwaziswa ngesimo sami
negciwane lengculazi kuyoba ngudokotela, yilowo ohlola ingaphakathi lomzimba okuthiwa yi-
ultrasonographer kanye nabahlengikazi abafikayo abasezingeni eliphezulu.
3.Ngingayeka ukuzibandakanya noma nini kulolu cwaningo ngaphandle kokusatshiswa.
4.Ngizimisele ukuba mdibi munye kulolu cwaningo.
Isishicilelo sesiguli
Sayina:  .....................................................................Usuku ............................
Umuntu okunike incazelo ngalesi sivumelwano
Sayina:  .............................................................Usuku ............................
Umuntu okunike incazelo ngalesi sivumelwano
Sayina . ....................................................	Usuku ............................
Ufakazi




1. Positive blood cultures for IE 2. Evidence of endocardial involvement
(a) Microorganisms typically associated (a) an oscillating intracardiac mass, located at
with IE from 2 separate blood cultures,
these are viridans streptococci,
streptococcus boris; HACEK group
a site where vegetations typically occur,
e.g. valves, chordae, atrial septal defects,
ventricular septal defects, and along the
(Haemophilus species, Actinobacillus
actinomycetemcomitans,
path of a turbulent jet.
(b) intracardiac abscesses
Cardiobacterium homonis, Eikenella
species, and Kingella kingae); or
community acquired staphylococcus
aureas or entrococci.
(b) Microorganisms that are consistent
with IE from persistently positive
blood cultures, which are defined as >
(c) dehiscence of a prosthetic valve
(d) detection of a new regurgitant murmur
2 positive cultures of blood drawn > 12
hours apart or > 4 separate cultures
with the first and last samples drawn >
1 hour apart58.
Ref: Predergast, B.D. I leant. 2004: 90: 61 I — 613.
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Duke Criteria: Minor
1. Predisposition to heart disease
2. Fever > 38 degrees absence of which can be considered
negative predictive value.
3. Vascular phenomena arterial emboli; septic pulmonary infarcts;
mycotic aneurysms; intracranial hemorrhage;
conjunctival hemorrhages; and Janeway
lesions.
4. Immunological phenomena glomerulonephritis; Osler's nodes; Roth spots;
and an elevated rheumatoid factor.
5. Microbiological when a bacterium is neither typical nor
persistent, it can still provide some supporting
evidence for the diagnosis of IE.
6. An echocardiogram consistent with
endocarditis, which does not meet with
major criteria (omitted from modified
criteria)
non-oscillating targets; new valvular
fenestrations; and nodular valvular thickening
8, 17 .




• Positive serology for Coxiella hurnetti
• Bacteremia due to staphylococcus aureas
• Positive molecular assay for specific gene targets and universal loci for bacteria and
fungi
• Positive serology for Chiamydia psittaci
• Positive serology for Bartonella species48
Additional minor criteria
• Newly diagnosed splenomegaly
• Newly diagnosed clubbing
• Splinter heamon-hages
• Petechiae and purpura
• High ESR, defined as more than one and one-half times the upper limits of normal
(>30 mm/h in patients < 60 years, >59mm/h in patients >60 years)
• High CRP levels, >100mg/L
• Microscopic heamaturia
• Central nonfeeding venous lines and peripheral venous lines
• Organisms from metatstatic lesions 4°
Ref: Lamas, C.C., and Eykyn, S.J. Clin Infect Dis. 1997; 25: 713 — 719.; McDonald, et al, Clin Infect Dis. 1994 18:648 - 649.
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Appendix 3: Referring Hospitals
HOSPITALS HIV(+) n=17 HIV(-) n=60 TOTAL
KEH 7 11 18
ADDINGTON 0 3 3
RICK 4 3 7
PMH 0 8 8
MGH 3 11 14
GREYS 0 5 5
IALCH 0 3 3
ST. MARY 0 1 1
NGWELEZANE 0 3 3
WENTWORTH 0 2 2
VRYHEID 0 1 1




KOKSTAD 0 1 1
MURCHISON 1 1 2
PARKLANDS 0 1 1
CITY 0 1 1
UMTATA 0 1 1
PORT SHEP 0 1 1
ST AUGUSTINE 0 1 1
OSINDISWENI 0 1 1
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APPENDIX 4a:
Diagnosis according to Duke Criteria
Patient Major Minor
Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
1 • • • 2 1 Def
2 • • • 2 1 Def
3 • • • 2 1 Def
4 • • • • • • 2 4 Def
5 • • 1 1 Pos
6 • . • • 1 3 Def
7 • • • • 1 3 Def
8 • • • • • 1 4 Def
9 • • • • • 1 4 Def
10 • • • 1 2 Pos
1 1 • • • • • 1 4 Def
12 • • • • 1 3 Def
13 • • • • . . 2 4 Def
14 . • • 1 2 Pos
15 • • . 1 2 Pos
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
16 1 2 Pos
17 • . • 2 1 Def
18 • • • • • 2 3 Def
19 . . • • . 2 3 Def
20 • • 0 2 Rej
21 • • • • 1 3 Def
22 • • • • 2 2 Def
23 . • 1 1 Pos
24 . . . 1 2 Pos
25 • • • • . 1 4 Def
26 • 0 1 Rej
27 • • • • • • 2 4 Def
28 • • 1 1 Pos
29 • . . . • 1 4 Def
30 • . • 1 2 Pos
31 • . . • 2 5 Def
32 • • • • • 2 3 Def
33 . . • . • 1 5 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
34 • • . 1 2 Pos
35 • • • • • 2 3 Def
36 • . • • • 1 4 Def
37 • • . • 2 2 Def
38 • • • • • • • 2 5 Def
39 • • • • 1 3 Def
40 1 1 Pos
41 • • • • . 1 4 Def
42 • • • • • 2 3 Def
43 • 1 0 Rej
44 • • 1 1 Pos
45 • . • . 2 2 Def
46 . . • . • • 2 4 Def
47 • • • • . • 1 5 Def
48 • . • • . • • 2 5 Def
49 • • . • 1 3 Def
50 • • • • • • • • 2 6 Def
51 , , . . 1 3 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Ilaem RF Maj Min Diag
52 1 3 Def
53 • • • 1 2 Pos
54 . • • • 4 Pos
55 • • • 1 2 Pos
56 • • • • . • 2 4 Def
57 • • • • 1 3 Def
58 • . • • 2 3 Def
59 • • • 1 2 Pos
60 • 0 1 Rej
61 • . 1 1 Pos
62 . . • 0 3 Pos
63 • • • • • 1 4 Def
64 • • • 1 2 Pos
65 • • • 1 2 Pos
66 • • . 1 2 Pos
67 • • • . 1 3 Def
68 • • • • • 2 3 Def
69 • • • • 2 2 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
70 • 1 0 Rej
71 • • • • • • • 2 5 Def
72 • • . . . • 2 4 Def
73 • . • • 1 3 Def
Pos
74 • . . . • 1 4 Def
75 • . • . . 1 4 Del
76 • . • • • 2 3 Def
77 • • • • 2 2 Def
78 • • . . • 1 4 Def
79 • • • • 1 3 Def
80 • • • • • • 2 4 Def
81 • • • • • • • . • 2 7 Def
82 . . • . 1 3 Del
83 . . • . • 2 3 Def
84 . . 1 1 Pos
85 • • . • 1 3 Def
86 • • • . 1 3 Def
87
Pos B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
87 • • • • 1 3 Def
88 • • • • • 1 4 Def
89 • • • • • 1 4 Def
90 • • • • • • 1 5 Def
91 • • • 1 2 Pos
KEY
Neg negative
B/cul+ positive blood culture
Echo echocardiographic features of IE
Club clubbing
Splint splinter heamorrhages
Va Vascular phenomena / stroke
Splen splenomegaly




Maj number of major






Diagnosis according to modified Duke Criteria
Patient Major Minor
Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
1 • • • 2 1 Def
2 . • • 2 1 Def
3 • • • 2 1 Def
4 • • • • • • 2 4 Def
5 • • 1 1 Pos
6 • • • • 1 3 Def
7 • . • • 1 3 Def
8 . . • . • 1 4 Def
9 • • • • • 1 4 Def
10 • • • 1 2 Def
11 • . . 1 Def
12 • • • 1 3 Def
13 . • • . • 2 4 Def
14 • • • 1 2 Def
15 . • • 1 2 Def
89
Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
16 . • . 1 2 Def
17 • • • 2 1 Def
18 • • • • 2 3 Def
19 • • • • • 2 3 Def
20 • • 0 2 Rej
21 • • • . 1 3 Def
22 • • . • 2 2 Def
23 • • 1 1 Pos
24 • • • 1 2 Def
25 • • • • • 1 4 Def
26 • 0 1 Rej
27 • . • • • . 2 4 Def
28 . • 1 1 Pos
29 • • • • • 1 4 Def
30 • • • 1 2 Def
31 . . . • • • • 2 5 Def
32 . . • . • 2 3 Def
33 . • . . . 1 5 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Ilaem RF Maj Min Diag
34 • • 1 2 Def
35 • . . • 2 3 Def
36 • . • • 1 4 Def
37 . . • 2 2 Def
38 • • . • • . 2 5 Def
39 • . . 1 3 Def
40 • 1 1 Pos
41 . • • • 1 4 Def
42 • . . . . 2 3 Def
43 • 1 0 Rej
44 • • 1 1 Pos
45 • . • • 2 2 Def
46 . . . • . • 2 4 Def
47 • . . . . 1 5 Def
48 . . . . . . • 2 5 Def
49 • • • • 1 3 Def
50 • • • • • • • 2 6 Def
51 . • • • 1 3 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
52 • . • 1 3 Def
53 • 1 2 Def
54 • • • • 4 Pos
55 • • • 1 2 Def
56 • • • • • • 2 4 Def
57 • • • • 1 3 Def
58 • • • . • 2 3 Def
59 • . . 1 2 Def
60 . 0 1 Rej
61 . . 1 1 Pos
62 . • • 0 3 Pos
63 • . • • • 1 4 Def
64 • . • 1 2 Def
65 • . • 1 2 Def
66 • • • 1 2 Def
67 • • • • 1 3 Def
68 • • • • • 2 3 Def
69 • • . . 2 2 Def
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Neg B/cul+ Echo Fever Club Splint Va Splen ESR CRP Heam RF Maj Min Diag
70 • 1 0 Rej
71 • • • • • •
72 • • • • •
73 • • • • 1 3 Def
Pos
74 • • • • • 1 4 Def
75 • • • •
76 • • • • • 2 3 Def
77 • • • • 2 2 Def
78 • • • • • 1 4 Def
79 • • • • 1 3 Def
80 • • • • • 2 4 Def
81 • • • • • • • • • 2 7 Def
82 • • • • 1 3 Def
83 • • • • • • 2 4 Def
84 • • 1 1 Pos
85 • • • •
86 • • • •
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Pos B/cul+ Echo Fever Club Splint Va Splen ESR CRP Haem RF Maj Min Diag
87 • • • • 1 3 Def
88 • . • • • 1 4 Def
89 • • • • • 1 4 Def
90 • • . • • • 1 5 Def
91 • • • 1 2 Def
KEY
Neg negative
B/cul+ positive blood culture
Echo echocardiographic features of IE
Club clubbing
Splint splinter heamorrhages
Va Vascular phenomena / stroke
Splen splenomegaly




Maj number of major





APPENDIX 5: SURGICAL FINDINGS
Echo
findings



























































S. aureus Multiple vegetations IE Rheumatic
7. AO NCC
vegetation












S. viridans Thick MV, AO Chronic RHD Rheumatic


















S. aureus AML vegetation Serratia Valvulitis, RHD Rheumatic
14 AO NCC
vegetation
S. aureus Vegetation LCC,
NCC, AO abscess
- Gram pos cocci,
abscess
Rheumatic
I 5 AO NCC,
RCC
vegetation



























1 9 Multiple MV
AML
vegetations

























































































































B/culture blood cultures MV mitral valve
IE infective endocarditis PM 1. posterior mitral leaflet
Rh rheumatic findings at surgery AML anterior mitral leaflet
RFID rheumatic heart disease TV tricuspid valve
AO aortic FOC failure of coaption
NCC non coronary cusp SOV sinus of valsalva
RCC right coronary cusp Cal calcified
LCC left coronary cusp pos positive
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